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1. INTRODUCTION 
Cleft lip and/or palate (CL/P) includes cleft lip with or without cleft alveolus 
(CL±A), cleft lip and palate (CLP), and isolated cleft palate (CP). CL/P affects 
about 1 per 700 (or 14 per 10,000)  live births per year (Mossey and Castillia, 
2003). Most cases of CL/P, about 70%, are non-syndromic; i.e. the clefts occur 
without other anomalies (Stanier and Moore, 2004).  
CL/P not only affects appearance, but also feeding, speech, hearing, and 
psychological development. Patients often have to undergo multiple treatments 
starting at birth until young adulthood (Stanier and Moore, 2004). These treat-
ments involve specialists from different areas: anaesthesiology, audiology, 
genetic counselling, nursing, oral and maxillofacial surgery, orthodontics, 
otolaryngology, paediatrics, paediatric dentistry, plastic surgery, prosthodontics, 
psychiatry, psychology, social work, and speech-language pathology (American 
Cleft Palate-Craniofacial Association, 2018). The outcomes of cleft care, there-
fore, should be evaluated from different perspectives. A standard set of outcome 
measures for cleft care have been proposed; it contains eight major outcome 
domains: eating and drinking, dental and oral health, speech/communication, 
otologic health, breathing, appearance, psychosocial development, and burden 
of care (Allori et al., 2017a). 
The burden of CL/P is more significant in low- and middle-income countries. 
There are several barriers to CL/P treatment around the world: a lack of trained 
providers, patient travel costs, a lack of patient awareness, and little financial 
support for the provision of surgical care (Jenny et al., 2017). Specifically, in 
Vietnam, although most of the patients have health insurance, a majority of 
them still rely on charitable cleft care outside of the centralized health care 
system. For that reason, the treatment for patients with CL/P is usually behind 
the optimal timetable for treatment compared to developed countries (Yao et al., 
2016).  
Patients with CL/P in Central Vietnam are operated by different charity 
organizations, such as Operation Smile, Smile Train, Interplast, Chonbuk Uni-
versity operation team, and Global Care Korea. These charitable cleft operations 
have been performed for several years. The cleft care focused largely on 
surgery; other types of cleft treatment such as speech therapy and orthodontic 
treatment have not been provided. The follow-ups for these patients are usually 
fragmented. Treatment outcomes of these patients are, therefore, not investi-
gated comprehensively. 
The purpose of the present study is to evaluate the treatment outcomes of 
surgically treated patients with CL/P in Central Vietnam.  
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2. REVIEW OF LITERATURE 
2.1. Aetiology 
Causes of non-syndromic CL/P remain unclear. It is generally accepted that the 
aetiology of CL/P is multifactorial, i.e. genetic factors, environmental risk 
factors, and the interaction between them. Some growth factors, transcription 
factors, nutrient metabolism, or immune response have been studied (Mossey et 
al., 2009). Genes related to syndromic CL/P could possibly increase the risks of 
having non-syndromic CL/P (Wong FK and Hagg, 2004). There are some 
lifestyle and environmental risk factors that might play a role in CL/P such as 
maternal smoking, deficiency of folic acid and zinc, exposure to organic 
solvents and agricultural chemicals, consumption of anticonvulsant drugs and 
corticosteroids, or viral infection (Mossey et al., 2009).  
 
2.2. Classification 
There have been several classifications of CL/P based on the anatomic and 
morphologic, or embryologic perspectives (Allori et al., 2017b). Davis and 
Ritchie (1922) proposed a three-group system of CL/P classification using the 
alveolar process as a dividing line: 1) prealveolar process cleft; 2) postalveolar 
process cleft; 3) alveolar process cleft. Fogh-Andersen (1942) suggested using 
the incisive foramen as a dividing line from an embryological perspective. He 
proposed a four-group system: 1) cleft lip (CL) extending to the incisive 
foramen and including clefts of the alveolus; 2) CL and CP; 3) CP identified as 
being always median and not extending beyond the incisive foramen; 4) rare 
atypical clefts, e.g. median cleft lip. Kernahan and Stark (1958) supported the 
use of the incisive foramen and proposed three groups: 1) clefts of structures 
anterior to the incisive foramen; 2) cleft of structures posterior to the incisive 
foramen; 3) clefts of structures anterior and posterior to the incisive foramen. 
The varieties of clefts can be grouped into three main categories (Berkowitz, 
2013). First, clefts may involve the lip and alveolus (i.e. CL±A). A cleft of the 
lip may be complete or incomplete, and it may be unilateral or bilateral. A 
complete cleft of the lip extends from the vermilion border to the floor of the 
nose. A bilateral CL may be symmetrical or asymmetrical (Berkowitz, 2013). 
Second, clefts that involve the lip and palate (i.e. CLP). CLP may be complete 
or incomplete, and it may be unilateral or bilateral. Direct communication 
between the oral and nasal cavities exist on the cleft side of the palate in a 
complete unilateral CLP. The bilateral CLP may be symmetrical or asym-
metrical (Berkowitz, 2013). Third, clefts that involve the palate alone (i.e. CP). 
This type of cleft does not involve either the lip or the alveolar process. It may 
involve only the soft palate or both the soft and hard palate but never the hard 
palate only. A subcategory in the CP is submucous CP. It has a classic 
diagnostic triad: bifid uvula, a furrow along the midline of the soft palate, and a 
bony notch in the posterior hard palate (Berkowitz, 2013). 
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2.3. Prevalence 
The overall prevalence of cleft lip with or without cleft palate (CL±P) is 9.92 
per 10,000 births, that of CL is 3.28 per 10,000 births, and that of CLP is 6.64 
per 10,000 births (IPDTOC Working Group, 2011). Prevalence of CL/P varies 
depending on the type of cleft, ethnicity, and gender. 
In term of the type of cleft, CLP generally occurs twice as often as either CL 
or CP individually. Unilateral clefts are more frequent than bilateral clefts; 
unilateral clefts occur more frequently on the left than on the right (Perry and 
Zajac, 2016). 
Regarding ethnicity, Asians (Japan, the Philippines) and mixed-race popu-
lations (Amerindians, mestizo populations) have the highest rates of CL/P, with 
intermediate levels in Caucasians, and the lowest level in Africans (Dixon et al., 
2011; Mossey and Castillia, 2003). The prevalence of CL/P in the Asian popu-
lation is 13.0 per 10,000 births (Cooper et al., 2006). 
CL±P is more dominant in males, and CP occurs more frequently in females 
(Mossey et al., 2009; Mossey and Castillia, 2003). The gender ratio (male/female) 
is 1.81 among cases with CL±P, and 0.93 among cases with CP (Mossey and 
Castillia, 2003). It is hypothesized that the secondary palate of the female 
embryo closes at a slower rate than that of the male embryo. Since the female 
secondary cleft is open for a longer period of time, it might be susceptible to 
teratogenic disruption during normal palatal closure for a greater period of time 
(Burdi and Silvey, 1969). 
 
 
2.4. Cleft-related problems 
Patients with CL/P often encounter multiple problems from birth: feeding diffi-
culties, dentofacial and orthodontic abnormalities, abnormal speech, hearing 
loss and ear infections, breathing problems, differences in appearance, and 
psychosocial functioning problems (American Cleft Palate-Craniofacial 
Association, 2018; Nackashi et al., 2002; Stock and Feragen, 2016). Therefore, 
the patients require a multidisciplinary treatment including plastic and maxillo-
facial surgery, otorhinolaryngology, orthodontics, speech and language therapy, 
and psychological therapy (Stock and Feragen, 2016). 
 
 
2.4.1. Feeding 
Neonates with CL/P have persistent feeding problems that can persist, in some 
cases, to 14 months of age (Reid et al., 2006). Neonates with CP and CLP have 
oronasal communication which makes them unable to create negative intraoral 
pressure to suckle (Peterson-Falzone et al., 2017). The inability to suck can lead 
to inefficient feeding that in turn results in an excessive air intake, longer 
feeding times, slow weight gain, and fatigue for both the baby and mother. 
Nasal regurgitation is also a common problem in CP (Goswami et al., 2016; 
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Peterson-Falzone et al., 2017; Jindal and Khan, 2013). Neonates with CL±A, on 
the contrary, usually do not have problems feeding because breast tissue covers 
the cleft during nursing (Peterson-Falzone et al., 2017). 
 
 
2.4.2. Dental and oral health 
Dental and oral health status is determined by caries status, oral hygiene status, 
and gingival status (Paul and Brandt, 1998). Systematic reviews and meta-
analysis studies have found conflicting results in the prevalence of caries in 
patients with CL/P. A systematic review found no firm confirmation that 
patients with CL/P have an increased prevalence of caries due to a low to 
moderate quality of the studies (Hasslof and Twetman, 2007). Others concluded 
that patients with CL/P tend to have a higher prevalence of caries in both 
primary and permanent dentition (Antonarakis et al., 2013; Wong FWL and 
King, 1998; Pinto et al., 2013). Patients with CL/P have poorer oral hygiene and 
more gingivitis but not conclusively a higher risk of developing periodontal 
diseases (Wong FWL and King, 1 4, 27, 28, 33, 34, 46, 47, 113.998; Paul and 
Brandt, 1998; Mutthineni et al., 2010). 
Patients with CL/P are characterized by class III malocclusion and crossbite. 
The class III malocclusion is due to maxillary hypoplasia that results from cleft 
surgery. Crossbite is frequently on the cleft side and in the incisor region (Para-
dowska-Stolarz and Kawala, 2014). 
The cleft is associated with a wide range of dental anomalies, and the dental 
anomalies occur more frequently on the cleft side. The most common dental 
anomalies found in patients with CL/P are: multiple missing teeth/hypodontia 
(usually the maxillary lateral incisors); neonatal teeth; ectopic teeth; impaction; 
supernumerary teeth; microdontia; maxillary canines and premolars trans-
position; crown and root malformation; enamel hypoplasia (Haque and Alam, 
2015; Kaul et al., 2017). 
 
 
2.4.3. Speech 
While CL should have no effect on speech once the clefts are operated on, CP 
can affect speech and communication abilities in many ways. CP is the most 
common cause of velopharyngeal insufficiency (VPI). VPI can impact on 
articulation, speech resonance, and nasal air emission (Peterson-Falzone et al., 
2017).  
There are two types of articulation errors: obligatory and compensatory 
errors. Obligatory errors are errors due to structural abnormalities such as 
misaligned teeth or oronasal fistula. The underlying structural deformities need 
to be corrected before speech therapy. Compensatory errors are errors due to 
maladaptive articulatory placement learned by children. This type of error can 
be corrected only with speech therapy (Nagarajan et al., 2009). 
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Resonance disorders include hypernasality (too much nasal resonance), 
hyponasality (too little nasal resonance), and mixed nasality (resonance cha-
racterized by elements of hypernasality and hyponasality) (Peterson-Falzone et 
al., 2017). The most common disorder of resonance is hypernasality (Sell et al., 
2001). 
Nasal air emission is the inappropriate release of air pressure through the 
nasal cavity that affects the high-pressure consonants that require oral airflow 
under pressure. Nasal emission can be audible or inaudible (Peterson-Falzone et 
al., 2017). 
 
2.4.4. Otolaryngologic health 
The incidence of hearing problems in CL alone is the same as non-cleft 
individuals because the cleft does not affect the Eustachian tube (Sharma and 
Nanda, 2009). Infants with CP and CLP, in contrast, universally present with 
otitis media with effusion. Otitis media with effusion is a condition which 
presents with middle ear fluid without signs or symptoms of acute infection 
(Flynn et al., 2009). The main pathogenesis of otitis media in children with 
clefts is Eustachian tube dysfunction resulting from the tensor veli palatini and 
the levator veli palatini incompetence (Flynn et al., 2009; Antonelli, 2002).  
Otitis media with effusion is clinically rather silent. The most common 
clinical manifestation of otitis media with effusion is a conductive hearing loss 
(Antonelli, 2002). The hearing loss can be temporary, persistent, or recurrent, 
and it can vary in degree. The amount and viscosity of the fluid in the middle 
ears can influence the degree and configuration of the hearing loss (Gravel and 
Wallace, 2000).  
 
2.4.5. Airway and breathing 
CL/P is frequently associated with nasal deformities such as a deviated septum, 
vomerine spurs, nostril atresia, alar constriction, and maxillary constriction 
(Cheung and Oberoi, 2012; Warren et al., 1988). These deformities tend to 
reduce the size of the nasal airway, increase nasal resistance to airflow, and 
reduce nasal patency (Fukushiro and Trindade, 2005). The type of cleft also 
affects the size of the airway. Children with bilateral CLP (BCLP) have the 
largest airway, followed by unilateral CL, CP, and unilateral CLP (UCLP) 
(Warren et al., 1988). However, adults with BCLP have a smaller nasal area 
than ones with UCLP, and ones with CP have an uncompromised nasal area 
(Fukushiro and Trindade, 2005). Nasal airway size differences due to cleft types 
might not remain over time. The growth might have a positive effect on the 
nasal size in patients with CL/P but not normalize it to be the same as non-cleft 
individuals (Drake et al., 1993). 
Patients with CL/P also have a reduced size of the pharyngeal airway 
because of changes in the craniofacial morphology and cleft surgery (MacLean 
et al., 2009; Agarwal and Marwah, 2016). Some studies have found that the 
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pharyngeal airway is restricted in patients with CLP (Shahidi et al., 2016; 
Agarwal and Marwah, 2016). However, others have found no differences in the 
pharyngeal airway volume between children with and without CLP (Pimenta et 
al., 2015; Cheung and Oberoi, 2012). 
 
 
2.4.6. Appearance 
The treatment of CLP should provide good aesthetic and functional results. 
Aesthetics and facial aesthetics, particularly, play an important role in an 
individual’s general perception of life (Sinko et al., 2005). Patients with CL/P, 
especially, may feel different from others in their facial appearance despite the 
fact that multiple surgical and other interventional procedures have been per-
formed until adulthood (Feragen and Stock, 2016). The differences in appea-
rance may have negative psychosocial consequences (Rankin and Borah, 2003). 
 
 
2.4.7. Psychosocial functioning and mental health 
CL/P and its treatment may have an impact on psychological and social func-
tioning—psychosocial functioning (Stock and Feragen, 2016; Hunt et al., 2005). 
Impacts on psychological functioning include: anxiety, self-esteem, depression, 
and behavioural problems (Hunt et al., 2007). Impacts on social functioning are 
related to teasing/bullying, schooling and further education, satisfaction with 
appearance, satisfaction with speech, marriage, and friendship (Hunt et al., 
2007; Hunt et al., 2005).  
Children with CP often have depressive symptoms, anxiety, and learning 
problems; which are related to the degree of speech difficulties. Children with 
CL have low self-esteem, depressive symptoms, and anxiety related more to 
facial appearance (Millard and Richman, 2001). Children with CL/P have a high 
level of internalizing behaviour and a low level of externalizing behaviour 
(Millard and Richman, 2001; Hunt et al., 2005). Adults with CL/P are more 
anxious and depressed than controls (Hunt et al., 2005; Ramstad et al., 1995). 
Dissatisfaction with appearance is a predictor of depression in patients with 
CL/P (Hunt et al., 2005; Marcusson et al., 2002). 
Having been teased, bullied or taunted is the predominant predictor of 
psychosocial impairment (Hunt et al., 2007). This may lead children to quit 
school to avoid being teased (Lorot-Marchand et al., 2015). Often, these indivi-
duals have no aspiration for further education and are usually unemployed with 
a low-income aspiration (Hunt et al., 2005; Peter et al., 1975). Some patients are 
pleased with their facial appearance, but many are not satisfied and desire 
further treatment (Hunt et al., 2005; Slifer et al., 2003; Marcusson et al., 2002); 
others are not satisfied with their appearance but appear to be tired of further 
treatment (Sinko et al., 2005). Few adolescents with CL/P are dissatisfied with 
their speech (Hunt et al., 2005). Few adults with CL/P marry (Broder et al., 
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1994; Hunt et al., 2005). If a marriage does happen, it is usually later in life and 
frequently childless. Children and young adults with CL/P have fewer friends 
than their non-cleft peers (Hunt et al., 2005; Bressmann et al., 1999). 
Children with CL/P have an increased risk of poor mental health because of 
low self-esteem, depressed mood, and hearing and speech deficits (Tillman et 
al., 2018). Danish adults with CL/P have been shown to have an increased risk 
for psychiatric disorders, all-cause mortality, and suicide (Christensen and 
Mortensen, 2002; Christensen et al., 2004). Swedish children have been shown 
to have an increased risk for psychiatric disorders, intellectual disability, lan-
guage disorder, autism spectrum disorder, attention-deficit/hyperactivity dis-
order, psychotic disorder, other behavioural and emotional disorders with onset 
in childhood, and personality disorders. However, Swedish children did not 
show increases in suicides, anxiety disorders, depression, bipolar disorder, 
eating disorders, or alcohol or substance use disorder (Tillman et al., 2018). 
 
 
2.4.8. Parental experiences 
The feelings of parents upon the diagnosis of CL/P vary (Nelson P et al., 2012). 
Research tends to pay more attention to mothers’ feelings because of the 
maternal bond between a mother and a child (Vanpoelvoorde and Shaughnessy, 
1991). Fathers are less included in research because theory-driven research has 
often marginalized fathers and centralized mothers, difficulties in recruiting 
fathers for research, and an overall lack of attention to the father’s potential 
influence on their child (Phares et al., 2005; Zimmerman et al., 2000; Silver-
stein, 2002; Costigan and Cox, 2001). In general, parents’ common feelings are 
sadness, shock, anger, grief, and worry (Nelson P et al., 2012). Specifically, 
mothers reported strong feelings of shock, hurt, disappointment, helpless resent-
ment, hysteria, denial, or suicide (Natsume et al., 1987; Slutsky, 1969). Fathers 
reported feelings of shock, worry, and sadness (Zeytinoğlu et al., 2016). 
 
 
2.5. Treatment protocols and timings 
Treatment protocols and timing of surgery for CL/P varies between cleft 
centres. However, some treatment modalities are generally accepted (De 
Ladeira and Alonso, 2012; Nahai et al., 2005; Nackashi et al., 2002). 
During the first week after birth, counselling on feeding difficulties is given 
to the mother. As for babies with CL±A, breastfeeding is viable. Artificial 
nipples with a large soft base are effective when breastfeeding is not desired. In 
babies with CP, breastfeeding is more challenging, although it might be possible 
in the case of a narrow cleft (Devi et al., 2012). Any babies with feeding prob-
lems are advised to use specialized feeding equipment (Devi et al., 2012; Jindal 
and Khan, 2013). 
Surgical interventions are carried out from infancy to adolescence; different 
surgical techniques can be used at each stage (Posnick and Ruiz, 2002). Cleft lip 
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repair is usually performed at 2–3 months, or 3–6 months of age (Posnick and 
Ruiz, 2002; Ziak et al., 2010). A general rule for the timing of cleft lip repair is 
the rule of 10s: 10 weeks of age, 10 pounds (about 4500 grams), and serum 
haemoglobin of 10 mg/ml (Wilhelmsen and Musgrave, 1966). Cleft palate 
repair is carried out before 2 years of age, usually from 6 to 12 months of age 
(Posnick and Ruiz, 2002). The timing of cleft palate repair is to optimize the 
function of velum and palate before the beginning of speech development and 
pressure formation of the mouth (Nahai et al., 2005). Bone grafting takes place 
after the eruption of the permanent maxillary first molars, usually from 7 to 9 
years, to achieve reliable and efficient orthodontic anchorage for rapid arch 
expansion and to allow maximal transverse growth of the maxilla (Posnick and 
Ruiz, 2002). Orthognathic surgery is carried out when permanent dentition fully 
erupts, the teeth have been orthodontically aligned, and maxillomandibular 
growth is complete (14–16 years in females, and 16–18 years in males) 
(Posnick and Ricalde, 2004; Posnick and Ruiz, 2002). 
The initial speech evaluation and speech therapy, if needed, are carried out 
within 12–14 months of age (Nahai et al., 2005). Secondary cleft palate proce-
dures for the management of VPI could be carried out when VPI is consistent 
and related to an anatomic problem (Posnick and Ruiz, 2002). 
Dental care is also carried out from infancy to adolescence. The supervision 
of dental care includes the prevention and treatment of oral diseases, an 
assessment of the developing dentition, and treatment needs related to the cleft 
such as orthodontic and prosthodontic treatment. General dentists, paediatric 
dentists, and orthodontists are involved in this process (Farrington, 2002). 
 
 
2.6. Measuring outcomes in non-syndromic CLP treatment 
Auditing clinical outcomes is important to maintain and continually improve 
patient care. Any outcome measures that are used to audit clinical care must be 
reliable, reproducible, and valid (Sandy et al., 2012). There are a large number 
of outcome measures available in cleft care (Jones et al., 2014). However, there 
are several difficulties in measuring cleft treatment outcomes. First, it requires 
time, money, and a large sample to conduct randomized controlled trials in the 
treatment of CL/P. Thus, more studies involve the next level of evidence that is 
inter-centre comparisons of outcomes (Sandy et al., 2012). The outcome mea-
sures from several inter-centre studies are reported in Table 1. Second, no 
specific recommendations of which outcomes should be assessed, nor how the 
outcomes should be collected, analysed, and interpreted have been advised 
(Sitzman et al., 2014). Third, outcome measures are often not perfectly reliable 
and valid (Jones et al., 2014). Lastly, definite results of the treatment are not 
visible until later in a patient’s lifespan, up to two decades after the primary 
surgery. The final outcomes usually are unpredictable at the beginning of the 
treatment due to variations in growth and development as well as the level of 
cooperation of the patient (Sinko et al., 2005). 
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Sitzman et al. (2014) proposed three main domains for measuring outcomes in 
cleft care: clinical, psychosocial, and system-based parameters. The clinical 
domain includes general paediatrics, surgery, dental/orthodontic, speech, and 
audiology. The psychosocial domain includes psychological well-being and 
social functioning. The system-based parameters include cost, resource alloca-
tion, the process of care, and supplemental/ancillary services. Recently, Allori et 
al. (2017a) suggested to assess the outcomes in eight major outcome domains: 
eating and drinking; dental and oral health; speech, otologic health; breathing; 
appearance; emotional and psychosocial development; and aspects related to 
process of care or burden of treatment. The authors designed it as a minimum 
standard set of outcome measures; any extensions are complementary to the 
standard set. 
 
2.7. An overview of the CL/P situation in Vietnam 
2.7.1. Vietnam and its health care system 
Vietnam is located in Southeast Asia with an estimated 97 million inhabitants 
(Worldometers, 2019). The total area is about 331,212 km2 including numerous 
islands. There are 63 cities and provinces which can be grouped into three main 
regions: Northern, Central, and Southern Vietnam. Vietnam has focused on the 
development of advanced medical centres in Hanoi (Northern Vietnam), Hue 
(Central Vietnam), and Ho Chi Minh City (Southern Vietnam) (Pham, 2010). 
Thua Thien-Hue Province is composed of one provincial city (Hue), two 
district-level towns, and six districts. In Hue, there are three large hospitals that 
treat patients with CL/P from the Thua Thien-Hue Province and neighbour 
cities in Central Vietnam: Hue Central Hospital, Hue University Hospital, and 
Hue Odonto-Stomatology Hospital. 
Although Vietnam’s health care system was transformed from a fully public 
service system to a mixed public-private system in 1989, the public health care 
system still plays an important role in providing health services (Le et al., 
2010). Currently, there is a lack of a healthcare workforce in Vietnam with the 
number of doctors being quite low (8 doctors/10,000 people) (Takashima et al., 
2017). 
Vietnam’s public health care system consists of four administrative levels: 
national level, provincial level, district level, and commune level (Le et al., 
2010). Accordingly, public medical institutions are classified into four levels: 
national, provincial, district, and commune level. The primary public medical 
institution is commune health stations, about 11,000 health stations, which 
cover nearly all communes in Vietnam and are responsible for primary health 
care services. However, commune health stations have limited medicine and 
medical equipment, additionally, there are not many skilled doctors and nurses 
at these locations. Patients, therefore, might go to higher level medical 
institutions for examination and treatment (Sakano, 2015). Due to this, two to 
20 
three patients sharing a bed is becoming a common problem in many national 
and provincial hospitals (Takashima et al., 2017). 
In 1992, health insurance was introduced (Le et al., 2010). About 86.9% of 
the Vietnamese population had health insurance in 2018 (Anh Xuan, 2018). The 
health insurance covers 80–100% of medical expenses depending on indivi-
duals. Public medical institutions also run a referral system. The referral system 
affects the percentage that the health insurance covers, 40–70% of the expenses 
(EFY Việt Nam, 2014).  
 
 
2.7.2. Management of CL/P in Vietnam 
The prevalence of CL/P in Vietnam is unclear, and it is usually estimated from 
hospital registries. The estimated prevalence of CL/P in Vietnam is about 14.9 
per 10,000 births (Nagato et al., 1998), or 14.1 per 10,000 births (Phan and 
Hoang, 2007). Agent Orange, which was used as a herbicide during the Viet-
nam War, contained a synthetic dioxin compound—2,3,7,8-tetrachlorodibenzo-
dioxin (TCDD). It allegedly attributed the increased risk of many congenital 
anomalies including CL/P in Vietnam (Clapp et al., 2014; Nagato et al., 1998). 
However, there is no national registry for congenital anomalies, CL/P in parti-
cular.   
In spite of a high proportion of insurance coverage, patients as well as their 
families still depend on charitable cleft care mainly because of the high cost of 
care for local services, or their belief in the superiority of foreign doctors 
(Hoang and Nguyen, 2011; Lam et al., 2010; Yao et al., 2016). Many charity 
organizations come to Vietnam on a mission that brings smiles back to 
Vietnamese children, such as Operation Smile, Smile Train, Deutsche Cleft 
Kinderhilfe, Project Vietnam Foundation, and institutional teams. Specifically, 
in Hue, Operation Smile, Smile Train, Interplast, Chonbuk University operation 
team, and Global Care Korea have been collaborating with Hue Central 
Hospital, Hue University Hospital, and Hue Odonto-Stomatology Hospital to 
provide free surgery to patients with CL/P for many years. 
Surgical treatment provided by charity teams usually lags behind the optimal 
window of timing compared to developed countries (Yao et al., 2016). Cleft 
individuals have had their first cleft repair at an average age of 3.2 years 
according to Yao et al. (2016), or 2.6 to 3.8 years according to Swanson et al. 
(2017). Also, due to a limited timeframe within each mission, the team can 
usually perform the operation for one procedure of the surgery protocols, which 
can create a problem in the continuity of care for short-term medical missions 
(Hoang and Nguyen, 2011). 
There are four barriers to surgical cleft treatment in Vietnam: patient charac-
teristics, family education and socioeconomics, geographic location, and cleft 
treatment site features. Males are almost two times more likely than females to 
access surgical treatment before 18 months of age. Paternal education beyond 
secondary school is associated with timely surgery. Families living within 10 
21 
km from the nearest hospital are more likely to attain the surgery. Travel time, 
cost, and distance to the mission site are not associated with the timing of the 
treatment. Lastly, hearing about the cleft mission from family, friends, or social 
media channels are associated with timely treatment (Swanson et al., 2017). 
 
 
2.7.3. Research on CL/P in Vietnam 
A vast majority of research has focused on the comparison of surgical techni-
ques or the evaluation of surgical outcomes (Nguyen TD and Thai, 2004; 
Nguyen VT, 2013; Nguyen CT and Nguyen, 2007). Epidemiological studies on 
CL/P have been carried out in certain areas in Vietnam (Nguyen CU, 1999; Lam 
et al., 2010; Nguyen HL, 2006; Phan and Hoang, 2007). There are some studies 
about other aspects of CL/P, such as speech, and craniofacial morphology 
(Nguyen TTC, 2012; Vu et al., 2004; Huynh and Hoang, 2007).  
In short, prior research in Vietnam has investigated one single aspect of the 
cleft treatment outcomes. No research has studied the multiple aspects of the 
treatment outcomes in patients with CL/P, especially, in Central Vietnam.  
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3. AIMS OF THE STUDY 
The general aim of the study was to investigate the different treatment outcome 
aspects of patients with CL/P in Central Vietnam. 
The specific objectives were: 
1. To determine oral health status (caries experience and periodontal status) of 
patients with CL/P (Paper I); 
2. To explore maternal feelings of having a child with CL/P, their belief in the 
causation of CL/P, and changes in their postpartum life (Paper II); 
3. To evaluate the nasolabial aesthetics of patients with CL/P (Paper III); 
4. To establish normative nasalance scores for Vietnamese-speaking indivi-
duals (Paper IV) and investigate nasalance scores for Vietnamese-speaking 
patients with repaired CL/P (Paper V); 
5. To determine characteristics of craniofacial morphology, maxillary arch 
dimensions, palatal dimensions, and upper airway structures in patients with 
CL/P (Paper VI); 
6. To explore the satisfaction of patients with CL/P and their parents with the 
outcomes of cleft treatment (Paper VII). 
We hypothesized that surgically treated patients with CL/P in Central Vietnam 
had an acceptable or a moderate result for each treatment outcome. 
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4. MATERIALS AND METHODS 
4.1. Study population 
Clinical records of patients with CL/P operated on by foreign teams at the three 
aforementioned hospitals in Hue were hand-searched with ethical approval. 
Two of the hospitals had been documenting patients operated on by foreign 
teams since 2012. The other hospital allowed us to access a patient list from 
2016. Therefore, we collected clinical records of patients with CL/P from 2012 
to 2016 in the two hospitals. In the third hospital, we collected clinical records 
from 2016. The available information on a clinical record was composed of the 
patient’s contact, a simple diagnosis notation, and a brief description of the 
surgical method used. No dental models, radiographs, nor photos were included 
in the records. Besides searching through the clinical records, we also an-
nounced a recruitment for patients through national and local channels. 
We identified 234 patients who might have CL/P through the clinical re-
cords. The primary researcher (Nguyen VT) contacted the patients individually 
to explain the research and set up an appointment for the study. Among the 
identified patients, 56 patients agreed to participate in the study, 119 patients 
refused, and 59 patients were not able to be contacted. On the data collection 
days (21–24 March 2016), 87 patients showed up. We had more patients 
showed up than the number of patients agreed to participate; that might be 
because we had the announcement on national and local channels about the 
recruitment. However, we did not specify where they have learned about the 
recruitment. To determine eligibility for the study, an initial examination was 
conducted to confirm the diagnosis of non-syndromic CL/P. From the 87, six 
patients were excluded because of nasal deformity only without CL/P (n=4) or 
signs of intellectual disability (n=2). Therefore, a total of 81 patients were 
included in the study. Depending on the treatment outcome to be evaluated, 
specific inclusion and exclusion criteria were applied. Patients who were not 
eligible for the study still underwent an oral and dental examination, but their 
data was not analysed. Different control groups were used to compare against 
the cleft group on certain treatment outcomes. Details of the study samples in 
each publication are listed in Table 2. 
Patients in this study were operated on using the same treatment protocol 
provided by charity operation teams. The operation teams followed similar 
surgical techniques to repair the lip and palate in accordance with their timing. 
The lip was repaired for patients 6 to 12 months old using modified Millard or 
Tennison technique. The palate was repaired for patients 12 to 24 months old 
using V-Y pushback technique. The surgical procedures were performed by 
different surgeons. No orthodontic treatment, bone grafting, nor speech therapy 
were provided. 
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4.2. Treatment outcome measures 
4.2.1. General information 
Questionnaires were used to gather information about the patients (name, gender, 
age, city of origin), and their parents (occupation, educational attainment). 
Another questionnaire based on the manual of World Health Organization was 
used to assess dental visit habit and brushing habit of the patients (World Health 
Organization, 2013). The questionnaires were filled out either by the patients or 
their parents. 
Socioeconomic status was established using the occupation and educational 
attainment of the parents. Their occupations were classified into manual and 
non-manual labour categories. The parents’ educational attainment was grouped 
into three levels: high educational level (tertiary education or higher), middle 
educational level (secondary education), and low educational level (primary 
education or less). Parents with high socioeconomic status were identified as 
those with a non-manual labour and a high educational level. Parents with low 
socioeconomic status were identified as those with a manual labour and a low 
educational level. The remaining parents were identified as middle socio-
economic status (Zhu et al., 2010). 
 
 
4.2.2. Oral health status (Paper I) 
The oral health assessment comprised of an assessment of dental caries and 
periodontal status. To assess dental caries, the decayed, missing, and filled teeth 
(dmft/DMFT) index was used. The dmft index was used for primary teeth, and 
the DMFT index was used for permanent teeth. We recorded the dmft and 
DMFT indices separately for primary and permanent teeth in children with 
mixed dentition. The level of caries is defined as caries-free if dmft/DMFT is 0; 
very low if dmft/DMFT is < 1.2; low if dmft/DMFT is 1.2 to 2.6; moderate if 
dmft/DMFT is 2.7 to 4.4; high if dmft/DMFT is 4.5 to 6.5; very high if 
dmft/DMFT is > 6.5 (World Health Organization, 2013). 
To assess periodontal status, two indicators were used: gingival bleeding on 
probing and periodontal pocket depth. The presence or absence of gingival 
bleeding was checked at four sites—buccal, lingual, mesial, and distal—for 
each tooth. The periodontal pocket depth was measured in patients age 15 and 
older (World Health Organization, 2013).   
 
 
4.2.3. Maternal experiences (Paper II) 
We constructed a questionnaire with open-ended questions to collect informa-
tion regarding the feelings of the patient’s mother towards the cleft diagnosis, 
their belief or knowledge of causes of CL/P, and changes in their life because of 
their child with CL/P. 
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4.2.4. Nasolabial aesthetics evaluation (Paper III) 
Frontal and profile photos of each patient were taken using a Canon EOS 6D 
(Melville, NY). The photos were prepared for the rating process in three steps: 
1) photos were levelled according to the interpupillary line; 2) the images were 
then cropped into a trapezium shape to show only the nasolabial region in-
cluding the inner canthus, nasal bridge, nostrils, philtrum, and upper lip (Merca-
do et al., 2011); 3) image files were loaded into Microsoft Office PowerPoint 
2013 (Mountain View, CA). The slides were anonymized and coded. The final 
file was saved as a PDF file and sent to raters. 
There were five raters to evaluate the nasolabial aesthetics: one maxillofacial 
surgeon, one general dentist, one orthodontic resident, and two orthodontists. 
They evaluated the nasolabial aesthetics using three rating methods: five-point 
aesthetic index, visual analogue scale (VAS), and reference scores method. The 
raters familiarized themselves with the rating methods before conducting the 
evaluation. The raters could check reference photos (if provided) during the 
rating process. No time limit was enforced for the evaluation process. No 
calibration test was performed. To assess intra-rater reliability, the raters were 
asked to re-evaluate 20 randomly selected photos after four weeks. 
 
 
4.2.4.1. The five-point aesthetic index 
The five-point aesthetic index assessed four features of nasolabial aesthetics: 
nasal form, nasal symmetry, vermilion border, and nasolabial profile (Asher-
McDade et al., 1991). The raters were asked to rate each feature on a 5-point 
scale as follows: 1 = “very good appearance”, 2 = “good appearance”, 3 = “fair 
appearance”, 4 = “poor appearance”, and 5 = “very poor appearance”. The 
raters were provided with a complementary description (given by Mercado, 
2017) and colour reference photos of each feature to distinguish the scale of 
severity (Kuijpers-Jagtman et al., 2009; Mercado et al., 2011). The component 
score of each feature was determined by the average of the five ratersʼ scores. 
The total nasolabial score was achieved by averaging the component scores. 
Each slide of the PowerPoint file used in this method consisted of one frontal 
and one profile photo as shown in Figure 1. 
 
4.2.4.2. VAS 
The VAS was a 100-mm line representing a spectrum of aesthetics between 
least aesthetic (0 mm, on the left) and most aesthetic (100 mm, on the right) 
(Asher-McDade et al., 1991; Fudalej et al., 2017). The raters rated the overall 
nasolabial aesthetics of a patient by placing a mark across the line at a point 
reflecting their feeling at the time. The distance of the mark from the left end 
was measured by a ruler and transformed into continuous variables. No 
reference photos were provided for this method. 
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Similar to the five-point aesthetic index, each slide of the PowerPoint file 
used in this method consisted of one frontal and one profile photo as shown in 
Figure 1. 
 
Figure 1. A coded slide used for the five-point aesthetic index and VAS method with 
cropped frontal and profile photos 
 
 
4.2.4.3. Reference scores method 
The reference scores method used a numerical scale from 0 to 200 and a refe-
rence photo with a base score arbitrarily set at 100. The raters would increase 
the score above 100 if the aesthetics of the nasolabial region was considered 
better than the reference. If the aesthetics were considered worse than the refe-
rence, the raters would decrease the score below 100 (Prahl et al., 2006; Fudalej 
et al., 2017). The raters scored facial and profile views. The total numerical 
score was averaged from the facial and profile view scores. The reference 
photos used in this method were photos with the highest agreement among 
raters based on the five-point aesthetic index. Four photos were selected as 
reference photos: frontal and profile views of a male patient, and frontal and 
profile views of a female patient. There were four reference photos of Vietna-
mese patients and four reference photos of Estonian patients. 
About the slide of the PowerPoint file, each patient had two slides. One slide 
was composed of a patient’s frontal photo and a reference frontal photo (Figure 
2A). The other slide consisted of a patient’s profile photo and a reference profile 
photo (Figure 2B). 
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Figure 2. (A) A coded slide used for the reference scores method with a cropped frontal 
photo of a patient on the left and a reference frontal photo on the right. (B) A coded 
slide used for the reference scores method with a cropped profile photo of a patient on 
the left and a reference profile photo on the right. 
 
 
4.2.5. Nasalance scores (Paper IV, V) 
4.2.5.1. Speech material 
We developed speech material specifically for the Vietnamese language. The 
speech material included three stimuli: oral stimuli, oro-nasal stimuli, and nasal 
stimuli. The oral stimuli, which were devoid of nasal consonants, were com-
parable to the Zoo passage in English. It had 19 oral words and 18 oral sen-
tences. The oro-nasal stimuli were comparable to the Rainbow passage in 
English and had eight sentences (33.8% nasal consonants). The nasal stimuli, 
which were loaded with nasal consonants, had seven sentences (83.0% nasal 
consonants) (Appendix A). 
 
A 
B 
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4.2.5.2. Establishing normative nasalance scores (Paper IV) 
The speech assessment was conducted in a quiet room. Nasalance scores were 
obtained using the Nasometer II (model 6450) (PENTAX Medical, Montvale, NJ) 
and NasometerTM software (PENTAX Medical, Montvale, NJ). The Nasometer 
was calibrated daily before assessing participants’ speech according to the 
manufacturer’s instruction. The Nasometer headset was positioned on a partici-
pant’s head. Once the headset was positioned properly, the participants were 
instructed to repeat the stimuli after the examiner with a short pause in between. 
Mean nasalance scores and standard deviation of the three stimuli were reported.   
To perform the retest analysis, five children were randomly selected. The 
headset was removed entirely and re-positioned on the child’s head. The child 
was asked to repeat the stimuli as in the test session. 
 
4.2.5.3. Cleft speech assessment (Paper V) 
The Nasometer was calibrated similarly to the procedure of establishing norma-
tive nasalance scores, such that the headset was positioned on a patient’s head, 
the patient repeated the stimuli after the examiner, and mean nasalance scores 
and standard deviation were reported. No retest analysis was performed. 
The nasalance score of a patient was interpreted based on a cut-off score of 
25%. The cut-off score was obtained from normative nasalance scores for the 
Vietnamese-speaking population (from Paper IV). Thus, nasalance scores 
higher than 25% signalled an excessive amount of acoustic nasal energy or 
hypernasality. 
 
 
4.2.6. Cephalometric analysis (Paper VI) 
We evaluated craniofacial morphology and upper airway structures using lateral 
cephalograms. The lateral cephalograms were taken with Galileos (Dentsply 
Sirona, Germany) under the following settings: 9.4 seconds, 60–84 kV, and 10–
15 mA depending on gender, age, and body types. For a more accurate measure-
ment of the airway, the patient’s head was positioned so that the Frankfurt 
horizontal plane parallel to the floor (Uslu-Akcam, 2017). The teeth were in 
habitual occlusion and the lips were relaxed. The lateral cephalograms were 
traced and analysed digitally using Dolphin Imaging software (Dolphin Imaging 
& Management Solutions, USA) by one examiner (Nguyen VT). The examiner 
was trained and calibrated before doing the tracing for this study. To assess 
intra-rater reliability, 20 lateral cephalograms were randomly selected and re-
measured after a 4-week interval. Reference landmarks and cephalometric mea-
surements are described in Figure 3 and Table 3. 
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Figure 3. Cephalometric landmarks and planes. 
Nasion (N): the intersection of the internasal suture with the nasofrontal suture in the 
midsagittal plane. Sella (S): the centre of the pituitary fossa of the sphenoid bone. 
Basion (Ba): the most inferior posterior point of the occipital bone at the anterior 
margin of the occipital foramen. Anterior nasal spine (ANS): the tip of the anterior 
nasal spine. Posterior nasal spine (PNS): the tip of the posterior nasal spine. A point: 
the deepest point on the curve of the maxilla. B point: the most posterior point in the 
concavity along the anterior border of the symphysis. Pogonion (Pog): the most 
anterior point on the midsagittal symphysis. Menton (Me): the most inferior point of 
the symphysis. Gonion (Go): the most convex point where the posterior inferior curve 
of the ramus meets. Retrognathion (RGN): the most posterior point on the mandibular 
symphasis. Articulare (Ar): the posterior border of the neck of the condyle. Condylion 
(Co): the most posterior superior point of the condyle. Hyoid (H): the most superior 
and anterior point on the body of hyoid bone. Cv2tg: the tangent point at the superior 
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and posterior extremity of the odontoid process of the second cervical vertebra. C3: the 
most anterior and inferior point on the corpus of the third cervical vertebra. Cv4ip: the 
most inferior and posterior point on the corpus of the fourth cervical vertebra. Base of 
epiglottis (Eb): the deepest point of epiglottis. TT: tip of tongue. TD: tongue dorsum. 
TP: the most posterior point of the tongue. U: the most inferior tip of soft palate. U’: 
intersection of the posterior surface of the soft palate and the midline of PNS-U. So: the 
midpoint of the line S-Ba. ad2: intersection of the line PNS-So and the posterior 
pharyngeal wall. ad1: intersection of the line PNS-Ba and the posterior pharyngeal 
wall.  
MPW1: intersection of the line from U’ parallel to B-Go plane and the posterior 
pharyngeal wall. MPW2: intersection of the line from U parallel to B-Go plane and the 
posterior pharyngeal wall. MPW3: intersection of the line from TP parallel to B-Go 
plane and the posterior pharyngeal wall. LPW: intersection of the line from Eb parallel 
to B-Go plane and the posterior pharyngeal wall. PAS1: intersection of the B-Go line 
and the anterior pharyngeal wall. PAS2: intersection of the B-Go line and the posterior 
pharyngeal wall. 
SN plane (SN): line from S to N. Mandibular plane (MP): line from Go to Me. 
Palatal plane (PP): line from ANS to PNS. B-Go plane: line from B to Go. 
 
 
Table 3. Cephalometric measurements 
Measurements Description 
Craniofacial morphology 
SNA (o) The angle between line SN and NA 
SNB (o) The angle between line SN and NB 
ANB (o) The angle between line NA and NB 
SN-MP (o) The angle between SN and MP plane 
SN-PP (o) The angle between SN and PP plane 
Ar-GoMe (o) Gonial angle 
Ba-SN (o) Cranial base angle 
N-Me (mm) Anterior face height 
N-ANS (mm) Upper anterior face height 
ANS-Me (mm) Lower anterior face height 
S-Go (mm) Posterior face height 
S-Ar (mm) Posterior cranial base height 
Co-Go (mm) Ramus height 
Ba-N (mm) Total cranial base length 
S-N (mm) Anterior cranial base length 
S-Ba (mm) Posterior cranial base length 
ANS-PNS (mm) Maxillary depth 
Co-A (mm) Maxillary length  
Co-Gn (mm) Total mandibular length 
U1-SN (o) The angle between U1 and SN 
U1-PP (o) Upper incisor inclination to palatal plane 
L1-NB (o) The angle between U1 and NB 
L1-MP (o) Lower incisor inclination to mandibular plane 
U1-L1 (o)  Interincisal angle: the angle between the long axis of 
upper central incisor and lower central incisor 
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Measurements Description 
Tongue dimensions 
Tongue length (mm) The distance between Eb and TT 
Tongue thickness (mm) The distance between TD and Eb-TT line 
Hyoid bone positions 
H-MP (mm) The distance between H and MP plane 
H-C3 (mm) The distance between H and C3 
C3-RGN (mm) The distance between C3 and RGN 
H-RGN (mm) The distance between H and RGN 
Hyoid angle (o) The angle between H-Go and H-Me 
Pharyngeal airway dimensions 
PNS-ad2 (mm) Superior nasopharyngeal airway space (the distance 
between PNS and ad2) 
PNS-ad1 (mm) Inferior nasopharyngeal airway space (the distance 
between PNS and ad1) 
U’-MPW1 (mm) Superior oropharyngeal airway space (the distance 
between U’ and MPW1) 
U-MPW2 (mm) Middle oropharyngeal airway space (the distance 
between U and MPW2) 
TP-MPW3 (mm) Inferior oropharyngeal airway space (the distance 
between TP and MPW3) 
PAS min Retroglossal airway dimension (the distance between 
PAS1 and PAS2) 
Eb-LPW (mm) Hypopharyngeal airway space (the distance between 
Eb and LPW) 
PNS-Eb (mm) Vertical airway length 
Head posture 
SN-CVT (o) The angle between SN and Cv2tg-Cv4ip line 
Soft palate dimensions 
Soft palate length (mm) The distance between PNS and U 
Soft palate thickness (mm) The maximum thickness of soft palate measured on 
the line perpendicular to PNS-U line 
 
 
4.2.7. Dental model analysis (Paper VI) 
We obtained digital dental models from the participants using the intraoral 
scanner TRIOS® 3 Colour Pod (3Shape, Denmark). The model analysis con-
sisted of measuring maxillary arch dimensions (maxillary arch widths, maxil-
lary arch lengths) and palatal dimensions. The model analysis was performed 
using OrthoAnalyzerTM 2015 (3Shape, Denmark). To assess intra-rater reliabili-
ty, 20 digital models were randomly selected and re-measured after a 4-week 
interval. Reference points are described in Figure 4 and 5. 
The maxillary arch widths included intercanine width, interpremolar width, 
and intermolar width. The intercanine width was the distance between the left 
and right canines. The interpremolar width was the distance between the left 
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and right second premolars or second primary molars. The intermolar width was 
the distance between the left and right first molars. 
The maxillary arch lengths included canine arch length and molar arch 
length. The canine arch length was the distance from the midpoint of central 
incisors to the line connecting the canines. The molar arch length was the 
distance from the midpoint of central incisors to the line connecting the first 
molars. 
The palatal dimensions included palatal widths, palatal lengths, palatal 
depths, and palatal angles. The palatal width was the distance between the 
highest points on the gingival margins of the palatal surfaces of the left and 
right teeth (Kilpelainen et al., 1996). The palatal length was the distance 
between the frontal edge of the incisive papilla and the midpoint on the palatal 
width (Kilpelainen et al., 1996). The palatal depth was the distance between the 
midpoint on the palatal width and the palatal vault (Kilpelainen et al., 1996). 
The palatal angle was the angle between the lines connecting the highest points 
on the gingival margins and the point of the palatal vault on the midpalatal 
raphe (Kilpelainen et al., 1996). 
 
 
 
 
Figure 4. Reference points for the model analysis.  
I: the midpoint of the central incisors (or the diastema). I’: The frontal edge of the 
incisive papilla. C1 and C2: cusp tips of the canines. C1’ and C2’: the highest points 
on the gingival margins of the palatal surfaces of the canines. P1 and P2: the mesio-
lingual cusp tips of the deciduous second molars or the lingual cusp tips of the per-
manent second premolars. P1’ and P2’: the highest points on the gingival margins of 
the palatal surfaces of the premolars. M1 and M2: the mesiolingual cusp tips of the 
permanent first molars. M1’ and M2’: the highest points on the gingival margins of the 
palatal surfaces of the molars.  
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The centre of the facet was used in case the tip was worn away. If the tooth was 
not present, an estimated point of the mesiolingual or lingual cusp tip was 
chosen. In case the first permanent molars did not erupt, the intermolar width 
was not measured. 
 
 
 
 
Figure 5. Maxillary arch dimensions and palatal dimensions: (A) maxillary arch widths 
and palatal widths, (B) maxillary arch lengths and palatal lengths, (C) palatal depths, 
and (D) palatal angles. 
 
4.2.8. Patient satisfaction (Paper VII) 
4.2.8.1. The Cleft Hearing, Appearance, and Speech Questionnaire 
(CHASQ) 
We utilized CHASQ, which is a simple and easy-to-use, yet comprehensive, 
questionnaire that assesses satisfaction of a subject on 15 items: face, whole 
appearance, side view/profile, good-looking, nose, lips, chin, teeth, cheeks, hair, 
ears, eyes, speech, hearing, and noticeability (Appendix B). The 15 items can be 
grouped into two factors using an exploratory factor analysis with promax 
rotation. Factor 1 includes features that are associated with having been born 
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with a cleft. Factor 2 includes features that are less associated with having been 
born with a cleft (Cleft Psychology Special Interest Group (SIG), 2014). 
The subjects can rate their satisfaction on an 11-point scale ranging from 0 
(“very unhappy”, “not at all good-looking”, or “very noticeable”) to 10 (“very 
happy”, “very good-looking”, or “not at all noticeable”). The score 6–10 is the 
norm; 1–5 is less satisfied than the norm; and 0 is much less satisfied than the 
norm (Cleft Psychology Special Interest Group (SIG), 2014). 
The CHASQ was translated into the Vietnamese and Estonian languages 
following a validation process. The process consisted of three stages: forward 
translation, backward translation, and patient testing (Mapi Research Institute, 
2005). After testing, the final versions were released (Appendix C and D). 
 
 
4.2.8.2. Satisfaction assessment 
We assessed the satisfaction of both patients and their parents with the out-
comes of the cleft treatment. The parents and patients completed the CHASQ 
independently. They could have assistance from an interviewer when com-
pleting the questionnaire if they did not understand certain questions. The 
procedure was the same for the Vietnamese and Estonian samples. 
 
 
4.3. Statistical analysis 
The data was analysed using Statistical Package for the Social Science (SPSS) 
version 22.0 (SPSS Inc, Chicago, IL). The chi-square test was used to compare 
categorical variables. Independent t-test and one-way ANOVA were used to 
compare continuous variables. The difference was statistically significant when 
the p-value was smaller than 0.05. 
In paper III, intraclass correlation coefficient (ICC) based on a mean-rating 
(k = 5), absolute agreement, and two-way random-effects was used to calculate 
inter-rater reliability. ICC based on a mean rating (k = 5), absolute agreement, 
and two-way mixed-effects was used to calculate intra-rater reliability. For each 
ICC score, 95% confidence intervals (95% CI) were calculated (Koo and Li, 
2016). Cronbachʼs alpha (α) was used to calculate the reliability of the five-
point aesthetic index and reference scores method. 
In paper IV, test-retest reliability was examined by calculating differences in 
the mean scores between the test and retest sessions for each stimulus. The 
differences were categorized as being <1, ≥1 and <2, etc. The number of subject 
in each category was determined, then cumulative frequencies were converted 
into cumulative percentages (Van Doorn and Purcell, 1998; Whitehill, 2001). 
In paper VI, the intra-examiner errors of cast measurement were measured 
with a paired t-test (systematic error). The method errors of cephalometric 
measurement were calculated using Dahlbergʼs formula (Cançado and Lauris, 
2014; Dahlberg, 1940). 
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In paper VII, A Mann-Whitney U test was used to compare the differences 
in the ratings between Vietnamese and Estonian patients. A Wilcoxon signed-
rank test was conducted to compare the differences in the satisfaction between 
patients and their parents. A Spearman correlation coefficient was used to test 
the level of agreement between patients and their parents.  
 
 
4.4. Ethical considerations 
All studies were approved by the Ethics Committee of Hue University of Medi-
cine and Pharmacy (24th December 2015). The studies related to Estonian 
samples were additionally approved by the Ethics Committee of the University 
of Tartu (reference number 278/T-1). Informed consent was obtained from the 
patients, controls, and parents. In case the participants were younger than 18 
years, informed consent was obtained from their parents. In the consent form, 
participants also allowed to use their photos in printed publications. Informed 
consent was obtained before participants were included in the study. The ones 
who did not meet the inclusion criteria or did not want to participate were 
excluded from the study. 
Data using in the present studies such as questionnaires, speech assessment, 
models, photos, and radiographs were anonymized and coded. Only the primary 
researcher can link these codes back to the subjects. 
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5. RESULTS 
5.1. General information 
The ratio between female and male was 1:1. The ratio between CL±A, CLP, and 
CP was 1:3:1. There was a 1:1 female to male ratio for CL±A and CLP, 2:1 
female to male ratio for CP, 4:1 left to right-sided unilateral CLP, and 2:1 left to 
right-sided unilateral CL±A. The age of patients ranged from 1 to 54 years old 
with a median age of 6.0 years old. 
Most patients came from Thua Thien-Hue Province (80.8%): Hue (29.5%), 
district-level towns (16.7%), and districts (34.6%); the other patients came from 
neighbour cities in central Vietnam (19.2%). The socioeconomic status of 
parents was mostly middle socioeconomic status (63.6% of the father, 65.4% of 
the mother). 
Distribution of patients and demographic characteristics of the samples in 
our publications are described in Table 4. 
 
 
 
Table 4. Distribution of patients and demographic characteristics 
Publica-
tion  
No. 
Cleft group Control group 
Sample 
size 
Cleft 
types 
Median 
age 
(years) 
Gender 
(F/M) 
Sample 
size Ethnicity
Cleft 
types 
Median 
age 
(years) 
Gender 
(F/M) 
I 78 
15 
CL±A,  
46 CLP,  
17 CP 
6.0 40/38 – – – – – 
II 76 (parents) – – – – – – – – 
III 23 UCLP 6.0 13/10 33 Estonian UCLP 10.0 9/24 
IV – – – – 102 Viet-namese Non-cleft 7.0 57/45 
V 38 28 CLP,  10 CP 8.0 21/17 – – – – – 
VI 17 11 CLP,  6 CP 9.0 11/6 34 
Viet-
namese Non-cleft 9.5 13/21 
VII 29 
7 CL±A,  
15 CLP,  
7 CP 
15.0 19/10 27 Estonian
4 CL±A,  
17 CLP,  
6 CP 
12.3 11/16 
F: female; M: male; CL±A: cleft lip with or without cleft alveolus; CLP: cleft lip and palate; 
UCLP: unilateral cleft lip and palate;  
CP: cleft palate 
–: not applicable 
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5.2. Oral health status (Paper I) 
More than half of the patients (51.3%) visited dentists at least once a year due to 
the following reasons: treatment/follow-up treatment (47.5%); pain or trouble 
with teeth, gums, or mouth (42.5%). A majority of patients brushed their teeth 
at least once a day (87.2%) using a toothbrush (89.7%) with toothpaste (84.6%). 
Some patients reported other methods to clean their teeth including: scrubbing 
their teeth using gauze with or without saline, scrubbing the teeth with lime, 
brushing with salt, or rinsing with saline or mouthwash. 
Caries prevalence in patients with CL/P in Central Vietnam was 87.2%. 
Dental caries experience levels were classified as very high based on the 
dmft/DMFT index. The dmft of children with CL/P ≤ 5 years old was 7.4 ± 6.6. 
The dmft and DMFT of children with CL/P ages 6–12 were 9.0 ± 5.1 and 1.6 ± 
1.8 respectively. The DMFT of patients with CL/P ≥ 13 years old was 6.7 ± 5.0. 
No significant differences were found in the caries experience between the age 
groups, cleft types, side of the cleft, or gender (p > 0.05) except the DMFT 
between 6–12 years and ≥ 13 years old groups (p < 0.05) (Table 5). There was 
an association between caries experience and socioeconomic status of the 
parents (p < 0.05). There were no statistically significant differences in caries 
experience related to living areas (p > 0.05). 
 
 
 
Table 5. Caries prevalence and dmft/DMFT index of the study population  
  Caries prevalence dmft DMFT 
Age group ≤ 5 years 79.4% 7.4 ± 6.6 - 
6–12 years 100% 9.0 ± 5.1 1.6 ± 1.8 
≥ 13 years 86.4% - 6.7 ± 5.0 
Cleft type CL±A 86.7% 6.1 ± 4.8 4.9 ± 5.7 
CLP 89.1% 8.0 ± 5.6 4.1 ± 4.5 
CP 82.4% 9.2 ± 7.4 3.6 ± 3.6 
Side of cleft Unilateral 85.4% 8.2 ± 5.7 3.5 ± 3.1 
Bilateral 95.0% 6.4 ± 4.8 5.3 ± 6.3 
Gender Female 90.0% 8.9 ± 6.7 4.5 ± 4.1 
Male 84.2% 7.3 ± 5.3 3.6 ± 5.1 
dmft/DMFT: decayed, missing, and filled teeth; CL±A: cleft lip with or without cleft 
alveolus; CLP: cleft lip and palate; CP: cleft palate 
–: not applicable 
 
 
 
 
About 60% of patients with CL/P experienced bleeding on probing, and 5.3% 
(patients > 15 years old, n = 19) had periodontal pockets with depths of 3.5–5 
mm. The mean averages for the number of teeth without bleeding, and with 
bleeding were 18.5 ± 5.2, and 2.7 ± 3.7, respectively. There was a significant 
difference in the presence or absence of bleeding on probing between age 
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groups (p < 0.05) (Table 6). There was no association between periodontal 
diseases and socioeconomic status of the parents (p > 0.05). There were no 
statistically significant differences in periodontal diseases related to living areas 
(p > 0.05). 
 
 
Table 6. Gingival bleeding status of the study population  
  No bleeding  on probing 
Bleeding  
on probing p-value 
Age group ≤ 5 years 20 (58.8%) 14 (41.2%) 
0.004* 6–12 years 10 (45.5%) 12 (54.5%) 
≥ 13 years 3 (13.6%) 19 (86.4%) 
Cleft type CL±A 5 (33.3%) 10 (66.7%) 
0.712 CLP 20 (43.5%) 26 (56.5%) 
CP 8 (47.1%) 9 (52.9%) 
Side of cleft Unilateral 18 (43.9%) 23 (56.1%) 0.357 Bilateral 7 (35.0%) 13 (65.0%) 
Gender Female 14 (35.0%) 26 (65.0%) 0.180 Male 19 (50.0%) 19 (50.0%) 
CL±A: cleft lip with or without cleft alveolus; CLP: cleft lip and palate; CP: cleft 
palate;  
* p < 0.05 
 
5.3. Maternal experiences (Paper II) 
The mothers expressed their feelings of having a child with CL/P as a single 
feeling or a combined feeling. The single feelings were afraid, anxious, tired, 
varying degrees of sadness (sad or very sad). The combined feelings were: 
anxious and nervous; anxious and sad; misery and desperate; sad and afraid; sad 
and afraid to give birth; sad and cried; sad and depressed; sad and discouraged; 
sad and heartbroken; sad and shock; surprise and anxious. The most common 
feeling was sad (60.5% as a single feeling, or 84.2% as a combined feeling). 
The feelings of the mothers were not associated with the cleft type, prenatal, or 
postnatal diagnosis (p > 0.05). 
Almost half of the mothers could not think of what caused CL/P in their child 
(47.4%). Others listed several causes of CL/P according to their opinions: 
diseases or abnormal conditions (27.6%), medications (11.8%), chemicals (3.9%), 
or hereditary factors (9.3%). They believed CL/P could have been caused during 
pregnancy from: a common cold, fever, hyperthyroidism, meningitis, sleepless-
ness, stress, or old age during pregnancy. They mentioned the medications could 
be excessive vitamin A or anti-cold medicine; the chemicals could be dioxin or 
pesticide. Educational level or socioeconomic status did not affect the belief of 
the mothers (p > 0.05). 
Most of the mothers had support from their husband and/or family members 
(92.1%). About 40% of the mother reported that having a child with CL/P did 
not cause major changes in their life. Other mothers listed some challenges such 
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as financial issues, feeding problems, mental depression, or general difficulties. 
A majority of the mothers did not hide their child from the public (78.9%). The 
cleft type was not associated with the support from families nor changes in the 
mother’s postpartum life (p > 0.05). 
 
 
5.4. Nasolabial aesthetics (Paper III) 
The reliability of the five-point aesthetic index was good (α = 0.80), and the 
reliability of the reference scores method was acceptable (α = 0.69). The inter-
rater reliability test showed a moderate (ICC = 0.630, reference scores method) to 
a good agreement (ICC = 0.864, five-point aesthetic index) of the five raters. The 
intra-rater reliability agreement ranged from moderate to excellent reliability. 
Among the four features assessed in the five-point aesthetic index, the nasal 
symmetry was rated lowest (2.7 ± 0.9) in the Vietnamese sample, whereas 
nasolabial profile was rated lowest (2.7 ± 1.0) in the Estonian sample. No 
significant differences in nasolabial aesthetics between the two samples were 
observed (p > 0.05) except for nasal symmetry (Table 7). Overall, the nasolabial 
aesthetics of operated patients with CL/P in both samples showed a fair 
appearance regardless of the rating method. 
 
 
Table 7. Nasolabial aesthetics (mean score ± standard deviation) in the Vietnamese and 
Estonian samples evaluated by three methods 
  
Vietnamese 
sample  
(n = 23) 
Estonian 
sample  
(n = 33) 
p-value 
The five-
point 
aesthetic 
index 
Nasal form 2.8 ± 1.2 3.2 ± 0.9 0.241 
Nasal symmetry 2.7 ± 0.9 3.1 ± 0.8 0.039* 
Vermilion border 3.1 ± 0.8 3.0 ± 0.7 0.678 
Nasolabial 
profile 
3.1 ± 0.9 2.7 ± 1.0 0.076 
Nasolabial 
scores 
2.9 ± 0.8 3.0 ± 0.7 0.729 
VAS 
method 
VAS score 54.6 ± 14.0 53.7 ± 15.2 0.824 
Reference 
scores 
method 
Facial 103.7 ± 16.9 102.2 ± 17.7 0.752 
Profile 102.3 ± 12.1 110.1 ± 19.5 0.072 
Total 103.0 ± 12.4 106.2 ± 16.7 0.423 
VAS: visual analogue scale 
* p < 0.05 
 
 
  
41 
5.5. Nasalance scores (Paper IV, V) 
The test-retest reliability of obtaining normative nasalance scores was 
acceptable. The test-retest difference in mean nasalance scores was within seven 
points in over 85% of the children for the oral stimuli; within seven points in 
about 70% of the children for the oro-nasal stimuli; within ten points in over 
75% of the children for the nasal stimuli. 
The mean nasalance scores for non-cleft Vietnamese-speaking children were 
13.1% for oral stimuli, 30.7% for oro-nasal stimuli, and 56.9% for nasal stimuli. 
No significant differences between genders were found (p > 0.05). 
The mean nasalance scores for Vietnamese-speaking patients with CP±L 
were 30.2% for oral stimuli, 42.8% for oro-nasal stimuli, and 58.7% for nasal 
stimuli. More than half of the patients (52.6%) had hypernasality. Adult patients 
had significantly higher nasalance scores in three of the speech stimuli 
compared to the child patients (p < 0.05) (Table 8). 
 
 
Table 8. Nasalance scores (mean score ± standard deviation) for operated Vietnamese-
speaking children and adults with CP±L 
 Oral words Oral sentences Oral stimuli
Oro-nasal 
stimuli 
Nasal 
stimuli 
Children (n = 27) 24.6 ± 14.9 29.0 ± 17.4 26.8 ± 16.1 39.9 ± 12.6 56.8 ± 8.2 
Adults (n = 11) 35.0 ± 14.6 41.7 ± 15.1* 38.3 ± 14.8* 49.9 ± 12.1* 63.5 ± 7.4* 
Total (n = 38) 27.6 ± 15.4 32.7 ± 17.6 30.2 ± 16.4 42.8 ± 13.2 58.7 ± 8.5 
CP±L: cleft palate with or without cleft lip;  
* p < 0.05 
 
 
5.6. Craniofacial morphology and upper airway structures 
(Paper VI) 
The method errors for the linear and angular measurements were not 
statistically significant and did not exceed 1 mm and 1o, respectively (p < 0.05). 
The craniofacial morphology of children with CL/P included: a more acute 
cranial base angle (Ba-SN), shorter cranial base length (Ba-N), shorter and more 
retruded maxilla (Co-A, ANS-PNS, SNA), more class III skeletal (ANB), 
shorter anterior face height (N-Me, N-ANS, ANS-Me), and shorter mandibular 
length (Co-Gn). The upper airway structures of children with CL/P had a more 
anteriorly positioned hyoid bone, smaller inferior oropharyngeal airway space 
and retroglossal airway dimensions, and a shorter soft palate (Table 9). 
The craniofacial morphology of adults with CL/P also showed a class III 
skeletal, a hyperdivergent skeletal pattern, shorter anterior cranial base length, 
and shorter maxilla length. The upper airway structures of adults with CL/P had 
a more posteriorly positioned hyoid bone, and a shorter soft palate (Table 9). 
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5.7. Maxillary arch dimensions and palatal dimensions  
(Paper VI) 
The paired samples correlations ranged from 0.66 to 0.98. There were no 
statistically significant systematic errors (p < 0.05). 
Children with CL/P had significantly smaller dimensions of the maxillary 
arch in three-dimensional planes. They had significantly narrower arch widths 
and palatal widths at the canine and premolar level, shorter arch lengths and 
palatal lengths, and a shallower palate. However, the arch width and palatal 
width at the molar level were not significantly different (p > 0.05) (Table 10). 
Adults with CL/P had a significantly narrower arch and palatal widths (at the 
canine, premolar, and molar level), and shorter arch and palatal lengths. The 
palatal depths and angles were not significantly different between the cleft and 
non-cleft group (p > 0.05) (Table 10). 
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5.8. Patient satisfaction (Paper VII) 
Patients rated their satisfaction above the norm on a majority of CHASQ items. 
The satisfaction towards teeth and lips was rated below the norm by Vietnamese 
patients. Whereas, Estonian patients did not express their satisfaction below the 
norm for any items. Comparing between Vietnamese and Estonian samples, 
Vietnamese patients scored their satisfaction significantly lower than Estonian 
patients on every item (p < 0.05) except for speech (p > 0.05) (Figure 6). 
 
 
 
Figure 6. Median scores of each item of the CHASQ scored by Vietnamese and Estonia 
patients. The Mann-Whitney U test was used to compare the scores between 
Vietnamese and Estonian samples (* p < 0.05) 
 
 
Parents scored their satisfaction above the norm for all CHASQ items. Viet-
namese parents tended to rate their satisfaction higher than their children (p < 
0.05) (Figure 7A), whereas Estonian parents rated their satisfaction lower than 
their children (p < 0.05) (Figure 7B).  
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Figure 7. Median scores of each item of the CHASQ scored by (A) Vietnamese patients 
and their patients; (B) Estonian patients and their parents. The Wilcoxon test was used 
to compare the scores between the patients and their parents (* p < 0.05) 
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In both the Vietnamese and Estonian samples, no significant high or very high 
positive correlations were found between patients and their parents. In the 
Vietnamese sample, moderate and significant correlations were found in these 
items: face, nose, lips, teeth, and speech. In the Estonian sample, a moderate 
and significant correlation was found in only one item: nose (Table 11). 
 
 
Table 11. The correlations between patients and their parent on the satisfaction of 
CHASQ items determined by Spearman’s correlation coefficient (rho) 
 Country rho p-value 
Face Vietnam .64* <.001 
Estonia .28 .16 
Whole appearance Vietnam .18 .36 
Estonia .12 .54 
Side view/Profile Vietnam .10 .60 
Estonia .10 .61 
Good-looking Vietnam .41 .03 
Estonia .24 .23 
Nose Vietnam .53* <.01 
Estonia .60* <.01 
Lips Vietnam .65* <.001 
Estonia .41 .03 
Chin Vietnam .24 .21 
Estonia -.00 .98 
Teeth Vietnam .65* <.001 
Estonia .21 .29 
Cheeks Vietnam .11 .57 
Estonia .07 .75 
Hair Vietnam .16 .41 
Estonia -.02 .92 
Ears Vietnam .28 .14 
Estonia -.00 .99 
Eyes Vietnam .32 .09 
Estonia -.07 .73 
Speech Vietnam .60* <.01 
Estonia .43 .03 
Hearing Vietnam .48 .01 
Estonia .15 .45 
Noticeability Vietnam .10 .62 
Estonia .44 .02 
Bold formatting indicates significant correlations (p < 0.05).  
An asterisk (*) indicates both moderate and significant correlations (0.5< rho < 0.7 and 
p < 0.05). 
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6. DISCUSSION 
To the best of my knowledge, this is the first study to report different treatment 
outcome aspects of surgically treated patients with CL/P in Central Vietnam. 
The study investigated the patient’s oral health, nasolabial aesthetics, speech, 
craniofacial morphology, maxillary arch dimensions, palatal dimensions, and 
upper airway structures. Moreover, we evaluated the patient’s satisfaction with 
the treatment outcomes and maternal experiences of having a child with CL/P. 
The results rejected the null hypothesis that patients with CL/P in Central 
Vietnam had an acceptable or a moderate result for each treatment outcome, 
because only two outcomes (nasolabial aesthetics and satisfaction) were 
acceptable. The other outcomes on oral health status, speech, craniofacial 
morphology, maxillary arch dimensions, palatal dimensions, and upper airway 
structures were poor. 
 
 
6.1. Oral health status (Paper I) 
Patients with CL/P in our study demonstrated a very high level of dental caries 
experience. The level of caries was similar or even higher compared to other 
cleft populations (Besseling and Dubois, 2004; Al-Dajani, 2009; Britton and 
Welbury, 2010; Zhu et al., 2010; Xiao et al., 2015). Although the methods of 
control and prevention, as well as treatment for dental caries, are well-
developed, individuals with CL/P still have a higher caries experience compared 
to the general population (Pinto et al., 2013; Antonarakis et al., 2013). A 
number of reasons have been proposed to explain the scenario of high caries 
experience in patients with CL/P: dry mouth because of mouth breathing habit, 
reduction of salivary secretion rate, longer clearance time of food, high levels of 
caries-associated micro-organisms, less natural cleansing of the teeth by the 
tongue and saliva due to crowding teeth, and enamel hypoplasia (Cheng et al., 
2007; Zhu et al., 2010; Dahllof et al., 1989; Ahluwalia et al., 2004; Johnsen and 
Dixon, 1984). Additionally, parents might play a role in controlling caries. The 
parents tend to focus more on surgical procedures to correct the cleft rather than 
early dental care (Al-Dajani, 2009). Low socioeconomic status is a risk factor in 
the development of caries (Antonarakis et al., 2013). Misinformation or lack of 
education and prevention in oral health may contribute to the situation (Pinto et 
al., 2013). 
Besides those reasons, there are several explanations for the very high caries 
experience in our study. Patients as well as their parents prioritized cleft surgery 
and paid little attention to oral health. The patients did not have a good practice 
of cleaning their teeth and did not have regular dental check-ups. Most of the 
parents in our study had a low or middle socioeconomic status. Their socio-
economic status was correlated with an increased risk of caries experience. 
Vietnamese parents usually underestimated the importance of maintaining 
healthy primary teeth because they think primary teeth will be replaced by 
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permanent teeth later in their life.  Lastly, hidden sugar in Vietnamese dishes is 
a potential risk. Sugar is added not only to sweet dishes but also to other foods, 
such as savoury dishes and juices. 
Patients in our study experienced gingivitis but not periodontitis. Previous 
research also showed that patients with CL/P have gingivitis more frequently than 
non-cleft individuals (Dahllof et al., 1989). The prevalence of gingivitis is around 
80% (Fadeyibi et al., 2011; Lages et al., 2004; Ramstad, 1989). The major reason 
is the difficulty in cleaning teeth because of changes in the anatomy in the cleft 
region (Dahllof et al., 1989). The cleft deformity, surgical scars, or crowding can 
make it difficult to control plaque (Wong FWL and King, 1998; Stec-Slonicz et 
al., 2007). In our study, the patients reported brushing their teeth frequently; 
however, the gingival bleeding index was still high. We could infer that the 
patients did not perform a proper brushing technique to effectively remove plaque 
and achieve good oral health. The patients in our study did not receive presurgical 
orthopaedic appliances, orthodontic treatment, or bone grafting; therefore, those 
reasons could be ruled out.  
 
 
6.2. Maternal experiences (Paper II) 
In our study, the predominant feeling of the mothers of having a child with 
CL/P was sadness. The feelings of Vietnamese mothers were less extreme and 
aggressive compared to prior studies. It has reported that the mother usually 
feels shocked or surprised (Slutsky, 1969; Johansson and Ringsberg, 2004; 
McCorkell et al., 2012; Natsume et al., 1987; Vanz and Ribeiro, 2011). The 
difference in the feeling of the mothers in our study might be because of the 
following reasons. They might be aware of the CL/P from different resources; 
therefore, they were not shocked at the defect. They felt sad as a result of the 
disappointment of the defect and their inability to undo the defect. Due to a 
strong Buddhist influence in Vietnam, the mothers might also view the defect as 
bad karma and have a sympathetic attitude to the defect (Hutchinson et al., 
2011). Finally, changes in the family planning policy in Vietnam might have 
eased the mother’s initial feelings. Since the 1960s, the two-child policy was 
implemented to control the fertility rate in the chaos of the population explosion 
at that time. From the 2000s, the policy was changed into “each family should 
have two children” (Nam Phuong and Le Phuong, 2017). Since 2018, the 
Population Law stated: “couples will be self-determined about their child’s 
birth, the distance between births, and the number of children” (N.Q., 2018).  
Beliefs about the causes of CL/P are related to geographic location, and 
cultural attitudes (Mednick et al., 2013). “Unknown” is the most common 
response to causal attribution of CL/P by Vietnamese mothers. Beliefs were 
similar to people in Kenya, Russia, Cambodia, and Peru (Mednick et al., 2013); 
however, people in the UK reported “unknown” as the least common response 
(Nelson J et al., 2009). The difference might be due to the amount of prenatal 
counselling and education provided in developing and developed countries 
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(Mednick et al., 2013). Vietnamese mothers did not mention any supernatural 
causes or folk beliefs, which could be a positive effect of modernization. Some 
supernatural beliefs existed in other cultures such as “God’s will”, the punish-
ment of sins in the past life, or witchcraft (Weatherley-White et al., 2005; 
Mzezewa and Muchemwa, 2010). 
Vietnamese mothers had support from their husbands and/or other family 
members. They also did not hide their child with CL/P from the public. It was 
shown that mothers of a child with visible clefts perceived more social support 
than mothers whose child had less visible clefts (Sank et al., 2003). In some 
places, parents were anxious about exposing their child to new situations, or 
hide their child from the public for some time (Mzezewa and Muchemwa, 2010; 
Weatherley-White et al., 2005). 
 
 
6.3. Nasolabial aesthetics (Paper III) 
Changes in facial aesthetics, especially nasolabial aesthetics because of the 
cleft, could cause negative psychosocial consequences, difficulty in making 
friends, or problems in relationships with family and friends (Noor and Musa, 
2007; Rankin and Borah, 2003). Thus, it is important to evaluate nasolabial 
aesthetics as one of the cleft treatment outcomes (Witt and Marsh, 1997). In our 
study, nasolabial aesthetics were considered to have a fair appearance (naso-
labial scores: 2.9). Based on the five-point aesthetic index, our result was 
similar to other inter-centre studies: six European centres (nasolabial score: 2.8–
3.4), Americleft (nasolabial score: 2.8–3.0), and Eurocleft (nasolabial score: 
2.8–3.7) (Brattstrom et al., 2005; Asher-McDade et al., 1992; Mercado et al., 
2011). Despite differences in the treatment protocols such as presurgical 
orthopaedic appliances, bone grafts, various methods and the timing of lip and 
palate surgery, number of surgeons, and surgeon experience and skill, our study 
produced a comparable overall nasolabial aesthetics with the aforementioned 
centres. It is possible that patients might not need many treatments to achieve 
acceptable nasolabial aesthetics.  
Nasolabial aesthetics can be determined by an objective assessment or 
subjective assessment. Objective assessments of facial aesthetics are generally 
inadequate because they often rely on hard tissue analysis, neglect the harmony 
of the face, and are not grounded in socially accepted aesthetic standards (Alley 
and Hildebrandt, 1988; Vegter et al., 1997). Subjective assessment—human 
perception—on the other hand, can act as a reliable measurement as long as a 
group of raters is used to overcome potential subjectivity (Alley and Hilde-
brandt, 1988). In this study, we used a panel of five raters, three different 
subjective methods with reference photographs, and a descriptive note of the 
four nasolabial features to increase the reliability. 
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6.4. Nasalance scores (Paper IV, V) 
Patients with CL/P who have speech problems may also have problems with 
psychosocial functioning, difficulties with specific communication tasks, and 
problems with social relationships (Feeney et al., 2012). They could experience 
social exclusion and have feelings of introversion and low self-esteem 
(Henningsson et al., 2008; Shapiro et al., 2015). Therefore, it is essential to 
evaluate the speech outcome of cleft treatment. It is the cornerstone to make a 
decision for surgical revision procedures (Bickham et al., 2017). 
This study developed the standard passages for the Vietnamese language, 
established the normative nasalance scores, and introduced the speech outcomes 
of patients with CP±L in Vietnam. As the speech outcomes had shown, a high 
prevalence of hypernasality in the study was concerned.  
Instrumental assessment using the Nasometer has been proven to be an 
objective tool to assess nasalance in patients with CP and to complement the 
auditory perceptual assessment of speech (Pegoraro-Krook et al., 2014; 
Swennen et al., 2004). Nasalance scores obtained by the Nasometer are 
language dependent; thus, normative nasalance scores have been developed for 
many languages (Brunnegard and van Doorn, 2009; D'Haeseleer et al., 2015; 
El-Kassabi et al., 2015; Ibrahim et al., 2012; Karakoc et al., 2013). Also, since 
the distribution of phonemes in each language is different, standard passages for 
each language are needed (Keuning et al., 2002).  
To interpret the nasalance scores, a cut-off score is applied (Van Doorn and 
Purcell, 1998). The cut-off score is determined by assuming a limit of 2 
standard deviations beyond the mean (Van Doorn and Purcell, 1998). Since the 
mean scores of nasalance scores are dependent on the language, the cut-off 
score is also language-specific, for example 27% in the Brazilian Portuguese 
language, 29% in the Finnish language, or 32% in the English language 
(Dalston et al., 1991; Pegoraro-Krook et al., 2014; Haapanen, 1994). As for the 
Vietnamese language, nasalance scores for oral stimuli above 24.7% are con-
sidered hypernasal. Nasalance scores for nasal stimuli below 38.5% are deemed 
as hyponasal. Applying those findings to the present study, we found that 
hypernasality occurred in 52.6% (n = 20) of the patients. The occurrence of 
hypernasality was much higher than in other cleft studies, such as 10.2%–17.6%  
in children with UCLP in the UK, 11% in children with CLP and 38% in 
children with CP in Finland (Haapanen, 1994; Sell et al., 2001; Sell et al., 
2015). The reasons could be oronasal fistula, lacking speech therapy, or diffe-
rent surgical techniques. An oronasal fistula is recognized as a contributor to 
hypernasality (Sell et al., 2001). About two-thirds of patients in the UK study 
received speech therapy, whereas, in our study, the patients did not have speech 
therapy at all (Sell et al., 2001). The study in the UK also showed that the 
centralization of cleft services improved speech outcomes (Sell et al., 2015).  
 
 
53 
6.5. Craniofacial morphology and  
upper airway structures (Paper VI) 
Children with CL/P in our study possessed maxillary retrognathia, vertical 
dysplasia in the maxilla, and class III malocclusion. Those characteristics were 
well-documented in previous studies (Chen et al., 2012; Naqvi et al., 2015; Ebin 
et al., 2010). It is generally accepted that the normal growth of the maxilla is 
inhibited by scar tissue resulting from cleft surgery (Naqvi et al., 2015). 
Children with CL/P also had a significant reduction in their cranial base angle 
and mandibular length. Differences in the size and angulation of the cranial base 
were more likely related to genetic factors rather than postoperative scarring 
(Ebin et al., 2010). The smaller mandible was presumably to fit with the smaller 
and retruded maxilla, although, in fact, most of the children with CL/P had a 
Class III malocclusion (Gopinath et al., 2017).  
Children with CL/P had a smaller inferior oropharyngeal airway space and 
pharyngeal airway space (PAS) but not the nasopharyngeal airway or hypo-
pharyngeal airway. Adults with CL/P had no significant differences in terms of 
pharyngeal dimensions compared to non-cleft adults. Our findings mirrored the 
results of previous studies (Aydemir and Toygar-Memikoğlu, 2014; Aras et al., 
2012; Pimenta et al., 2015; Cheung and Oberoi, 2012). Several authors reported 
that juveniles (6–12 years) and adolescents (13–17 years) with CL/P had a 
reduced airway passage size, nasopharyngeal airway area, and PAS distance 
(Agarwal and Marwah, 2016; Aras and Dogan, 2017; Imamura et al., 2002). 
Adults with CL/P (17–45 years) had a significantly lower total and superior 
airway volume but not the inferior airway volume compared to controls 
(Shahidi et al., 2016).  
In our study, the hyoid bone position was obtained and modified from the 
hyoid triangle suggested by Bibby and Preston (1981). The hyoid triangle 
determines the hyoid bone position in three dimensions, is independent of the 
cranial reference plane, and minimizes incorrectness derived from changes in 
head posture (Bibby and Preston, 1981). We found that the hyoid bone was 
positioned more anteriorly. That position might reflect a habitual adaption to 
airway obstruction in the pharyngeal airway space (Wermker et al., 2012; Aras 
and Dogan, 2017). 
Although cone beam computed tomography (CBCT), or computed tomo-
graphy (CT) scans have been intensively used in recent years to study the 
airway structures, we used lateral cephalograms due to following reasons. 
Cephalometry is available at most hospitals and/or cleft centres in Vietnam and 
has a lower cost than CBCT or CT scans. Since CBCT is not indicated as 
routine radiology for all patients, it is easier to use cephalograms to compare 
with control groups (Jakobsone et al., 2010; SEDENTEXCT, 2012). We were 
also aware of the shortcomings of lateral cephalograms, such as magnification 
errors, superimposition of bilateral structures, difficulties in landmark identi-
fication, and a two-dimensional interpretation of three-dimensional structures 
(Jakobsone et al., 2010). 
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6.6. Maxillary arch dimensions and  
palatal dimensions (Paper VI) 
Patients with CL/P had a shorter arch length and narrower maxilla compared 
with those of the controls. This finding was in agreement with previous studies 
(Bittencourt Dutra Dos Santos et al., 2015; Gopinath et al., 2017; Ye et al., 
2010; Kilpelainen et al., 1996). Children with CL/P had a more pronounced 
constriction in the anterior regions, i.e. canine and premolar regions, but not in 
the molar regions. However, adults with clefts had narrower arches in both 
anterior and posterior regions. As for the palate height and palate angle, the 
significant differences between the cleft and control groups disappeared in the 
adult group. It seemed that adults with clefts caught up with the development of 
the palate in adulthood. As in the child cleft group, the palate depth was 
decreased, and the palate was flattened. 
There are some factors that might affect the dimensions of the maxilla in 
patients with clefts, including: genetic factors, the type and timing of surgery, 
the skill of the surgeon, and the type and extent of the cleft, high incidence of 
hypodontia, untreated caries in primary teeth, scars after cleft surgery, and 
abnormal positioning of the tongue (Gopinath et al., 2017; Heliövaara and 
Rautio, 2005; Heliövaara et al., 2014). Morphological changes in different 
regions of the hard palate might be a result of scarring, habitual position of the 
tongue, and orofacial function (Gopinath et al., 2017; Berwig et al., 2011). 
In this study, to eliminate bias in evaluating the transverse dimensions of the 
maxilla due to improper tooth position, such as buccal tipping, we measured the 
transverse dimensions at two landmarks: the tip (i.e. maxillary arch dimensions) 
and the palatal gingival margin of the tooth (i.e. palatal dimensions). Thus, we 
could determine the dimensions of the dental arch as well as the size of the 
palate. 
 
 
6.7. Patient satisfaction (Paper VII) 
Since health care is shifting from a traditional paternalistic approach to a 
patient-centred approach, patient-reported outcomes are becoming more 
important because treatment is viewed from patient’s perspective, and observer 
bias could be avoided (Black, 2013; Fix et al., 2018; Deshpande et al., 2011). 
However, validated cleft-specific instruments to collect patient-reported 
outcomes are scarce (Jones et al., 2014; Shaye, 2014; Wong Riff et al., 2017). 
The Cleft Hearing, Appearance, and Speech Questionnaire (CHASQ) was 
designed and validated specifically for patients with CL/P and their parents. The 
CHASQ has been used in daily practice in the UK for audit purposes (Cleft 
Psychology Special Interest Group (SIG), 2014). Because the CHASQ was 
developed in the English language, it was translated into Vietnamese and 
Estonian following a linguistically validated process (Mapi Research Institute, 
2005). 
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The CHASQ score interpretation suggests score above 5.0 is within the 
norm. Vietnamese patients scored their satisfaction with facial features, hearing, 
and speech above 5.0 except for lips and teeth. Therefore, the patients were 
most satisfied with their appearance, hearing, and speech. It is worth noting that 
among facial features, patients were least satisfied with their lips. It shows the 
major influence of the cleft on the satisfaction towards the lip and nose 
(Gkantidis et al., 2013). Patients’ satisfaction with teeth was low. It reflected the 
findings of a high prevalence of caries in Vietnamese patients with CL/P (Paper 
I). Also, patients did not receive orthodontic treatment, so they might not be 
satisfied with misaligned teeth (Noor and Musa, 2007). 
Vietnamese patients rated their satisfaction significantly lower than Estonian 
patients in most of the items. Some speculations for this were low self-esteem, 
lack of information, and their overall standard of beauty. It has been shown that 
Asian people self-rated lower on self-esteem than Western people (Cai et al., 
2007). Patients preferred knowing about their condition at an early age, i.e. 
before or during elementary school. Asian parents tend to hide information 
about CL/P from their child. The patients, consequently, did not fully under-
stand their condition until adulthood (Omiya et al., 2014). 
Agreement on the satisfaction with the outcomes of the cleft treatment 
between patients and parents was moderate in our study. Other studies also 
reported a low to fair/moderate agreement between patients and parents (Bjerke, 
2016; Noor and Musa, 2007; Gkantidis et al., 2015). Experiences related to 
CL/P might be different between patients and parents; thus, they could influence 
patients and their parents’ satisfaction differently and lead a low agreement 
between them (Gkantidis et al., 2013). Therefore, it is crucial to evaluate the 
patient’s satisfaction and include patient’s opinion in the treatment decision-
making process, not just parents and/or physician’s opinions (Noor and Musa, 
2007). 
The items of the CHASQ are related to facial features, hearing, and speech; 
they can be used to determine the satisfaction of patients and their parents with 
the cleft treatment outcomes. The CHASQ can be used to determine any 
significant differences between patients and parents in ratings of the features 
related to facial appearance, hearing, and speech. The CHASQ can also be used 
to determine any changes in the satisfaction of patients over time throughout the 
treatment process to discover if the patient might need psychological coun-
selling.  
 
 
6.8. Clinical suggestions 
In Vietnam, information related to patients with CL/P is mostly collected from 
hospital registries. No national statistics about CL/P are available (Phan and 
Hoang, 2007). Therefore, it is necessary to establish a national cleft registry to 
record and monitor patients with CL/P (Al-Dajani, 2009). From the registry, a 
follow-up and recall system should be established. Also, it is important to 
56 
establish standards of record-taking with a list of the minimally required records 
and any additionally recommended records (American Cleft Palate-Craniofacial 
Association, 2017). The minimal records are models, lateral cephalograms, 
photos, speech, audiometry, and patient/parent satisfaction (American Cleft 
Palate-Craniofacial Association, 2017). 
Patients who are operated on by charity operation teams usually pay atten-
tion to surgical procedures to correct the cleft. Oral health is often underscored 
and neglected. This study showed that patients were not satisfied with their 
teeth, and the caries experience was very high. Hence, it is crucial to promote 
awareness of oral health in the cleft population and integrate preventive dental 
regimens into the cleft protocol (Zhu et al., 2010; Wong FWL and King, 1998). 
Paediatric dentists and/or general dentists should be responsible and check the 
dental health of their patients to detect any dental problems at an early stage. 
Primary and secondary caries prevention should be implemented for patients 
with CL/P (Pinto et al., 2013; Dahllof et al., 1989). Preventive measures include 
education about oral hygiene maintenance, prophylaxis, fluoride application, 
and dietary advice (King et al., 2013). Dental education should be given not 
only to children but also to their parents and/or caregivers (Al-Dajani, 2009; 
Mutarai et al., 2008). Brushing techniques should be demonstrated to the 
patients, parents, and/or caregivers (Fadeyibi et al., 2011). 
When cleft centres are about to open in Central Vietnam, postgraduate pro-
grammes should be adjusted to provide additional training on cleft care, 
especially for maxillofacial surgeons, paediatricians, orthodontists, and speech-
language pathologists. Currently, in Central Vietnam, speech-language patho-
logists are scarce. There are some on-going courses to educate more speech-
language pathologists for the region. 
Cleft centres in Vietnam should improve and standardize cleft treatment 
protocols across the country to provide consistently superior outcomes. It 
facilitates the needs to compare the treatment outcomes between centres in 
Vietnam. Inter-centre comparisons could avoid the sampling bias and allow for 
direct comparison of the outcomes together with other major components of the 
treatment program (Shaw et al., 1992). It has also been proven that a centralized 
multidisciplinary cleft service improves treatment outcomes (Ness et al., 2015). 
 
 
6.9. Research limitation 
A major limitation of the study was the small sample size. Despite the effort to 
recall operated patients with CL/P, we could not establish a larger sample size. 
There were three main reasons: patients declined to be in the study; patient’s 
contacts were unreachable; no cleft registry was available. Some patients 
refused to participate in the study because they desired more intervention, not 
just a check-up; the long travel distance from their place to the study site; no 
reimbursement for travel costs. It was good that we had announced the call for 
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the study on television, since it increased the total number of patients who we 
contacted via phone. 
A sample size of 30 to 40 is recommended based on a 0.5 significant level 
and 80% power to enable significant power for sensitive and important outcome 
measures (Long et al., 2011). Although the sample size of our study was small, 
it still met the suggested minimum sample size. For that reason, our study 
represented a reliable and valid assessment of the outcomes in question. 
Disregarding the small sample size, the frequency of CL/P by sex and 
laterality in our study was similar to those described in the literature. Males 
were shown to be more prone to CL±P, while females were more prone to CP. 
CL/P was usually unilateral and more favourable on the left side (Mossey and 
Modellb, 2012; Dixon et al., 2011). The most common cleft type was CLP 
(Mossey and Little, 2002). Similar findings were also ascertained by other 
research in Vietnam (Lam et al., 2010; Nguyen TD and Thai, 2004). 
 
 
6.10. Future directions 
In the future, a longitudinal study and large sample size are needed to evaluate 
the long-term outcomes of the cleft treatment. It would be good to revisit 
patients with CL/P in the region after 10 to 15 years to evaluate treatment 
outcomes to see if there are any changes in the outcomes. Also, future research 
could investigate other outcome domains that the current study did not touch, 
for example: feeding difficulties, psychological issues, or aspects related to the 
process of care or burden of treatment. 
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7. CONCLUSIONS 
1. Patients with CL/P in Central Vietnam had a poor oral health status with a 
very high level of dental caries and signs of gingivitis but not periodontitis.  
2. Mothers of patients with CL/P mostly had a feeling of sadness because of 
the condition of their child. They did not report any superstitious or folk 
beliefs in causal attribution to CL/P. Their life did not have any major 
changes because of the child with CL/P. 
3. The patients had a fair appearance of nasolabial aesthetics regardless of the 
rating methods. Nasal symmetry was the least favourable feature among the 
four features assessed. 
4. The study established normative nasalance scores for non-cleft Vietnamese-
speaking children in the central regional dialect. The patients had a poor 
speech outcome with more than half of the patients having hypernasality. 
5. Some patients had Class III malocclusion. The airway space was reduced in 
children with CL/P but not in adults with CL/P. The maxillary arch and 
palatal dimensions were reduced in children with CL/P in three dimensions. 
However, adults with CL/P had a similar size of the palate compared to the 
controls. 
6. The patients and their parents were satisfied with the cleft treatment 
outcomes. The patients were less satisfied with features associated with 
having been born with a cleft. The agreement between the patients and 
parents ranged from low to moderate.  
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APPENDICES 
Appendix A: Speech stimuli 
A1. Oral stimuli 
A1.1. Oral words 
Hoa, Phở, Trẻ, Quýt, Pa-tê, Tai, Gà, Đỏ, Voi, Thỏ, Rổ, Bò, Xe, Dao, Sữa, Gió, 
Chó, Khế, Ly 
A1.2. Oral sentences 
Pa pa 
Bà Bảy bị bổ 
Tí tập tạ 
Đu đủ đỏ 
Con cò có cái cổ cao 
Gà gô gáy 
Xôi xúc xích 
Phì phà phì phò 
Vũ về vội vã
Lí la lí lắc 
Thỏ thích thơ 
Ríu ra ríu rít 
Chú chích chòe 
Tre trúc trơ trụi 
Khúc kha khúc khích 
Hà hả hê 
Dao dây dưa 
Su sửa sổ sách 
 
A2. Oro-nasal stimuli 
Quê hương là chùm khế ngọt 
Cho con trèo hái mỗi ngày 
Quê hương là đường đi học 
Con về rợp bướm vàng bay 
Quê hương là con diều biếc 
Tuổi thơ con thả trên đồng 
Quê hương là con đò nhỏ 
Êm đềm khua nước ven sông 
 
A3. Nasal stimuli 
Nu na nu nống 
Hỏi han mọi người 
Mênh mông sóng nước 
Ngày tháng năm 
Mình muốn tắm mưa 
Nói chuyện lan man 
Nhắn nhủ nhau nói năng nhẹ nhàng 
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Appendix B: The English version of the CHASQ 
Name Date of birth Date completed 
   
 
Some young people tell us that they are happy with their hearing, appearance and 
speech while others sometimes feel less happy. 
How do you feel about your hearing, appearance and speech? 
There are no right or wrong answers. 
Please tick one box for each question.
 
How happy are you with: 
1. How your face looks: 
Very 
happy 
Very 
unhappy 
2. The whole of your appearance:
Very 
happy 
Very 
unhappy 
3. Side view / profile: 
Very 
happy 
Very 
unhappy 
4. How good-looking do you think you are?
Very  
good-
looking 
Not at all  
good-
looking 
 
 
How do you feel about these parts of your face?
5. Nose: 
Very 
happy 
Very 
unhappy 
6. Lips: 
Very 
happy 
Very 
unhappy 
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7. Chin: 
Very 
happy 
Very 
unhappy 
8. Teeth: 
Very 
happy 
Very 
unhappy 
9. Cheeks: 
Very 
happy 
Very 
unhappy 
10. Hair: 
Very 
happy 
Very 
unhappy 
11. Ears: 
Very 
happy 
Very 
unhappy 
 
12. Eyes: 
Very 
happy 
Very 
unhappy 
13. How happy are you with your speech?
Very 
happy 
Very 
unhappy 
14. How happy are you with your hearing?
Very 
happy 
Very 
unhappy 
15. Overall how noticeable do you feel your cleft is to other people? 
Not at all 
noticeable 
Very 
noticeable 
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Appendix C: The Vietnamese version of the CHASQ 
Tên Ngày sinh Ngày lập phiếu 
   
 
Một số bạn trẻ nói với chúng tôi là họ rất hài lòng về khả năng nghe, vẻ bên ngoài 
và cách phát âm của họ, trong khi đó một số khác cảm thấy ít hài lòng hơn. 
Bạn cảm thấy khả năng nghe, vẻ bên ngoài và cách phát âm của bạn như thế nào? 
Không có câu trả lời đúng hay sai. 
Vui lòng đánh dấu chọn () vào một ô cho mỗi câu hỏi.  
 
Mức độ hài lòng của bạn với: 
1. Gương mặt của bạn  
Rất hài 
lòng 
Không hài 
lòng 
2. Toàn bộ vẻ bên ngoài của bạn:
Rất hài 
lòng 
Không hài 
lòng 
3. Mặt nhìn nghiêng: 
Rất hài 
lòng 
Không hài 
lòng 
4. Bạn nghĩ mình đẹp trai/đẹp gái đến mức nào?
Rất đẹp Không đẹp chút nào 
 
 
Bạn thấy những phần này trên khuôn mặt bạn như thế nào?
5. Mũi: 
Rất hài 
lòng 
Không hài 
lòng 
6. Môi: 
Rất hài 
lòng 
Không hài 
lòng 
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7. Cằm: 
Rất hài 
lòng 
Không hài 
lòng 
8. Răng: 
Rất hài 
lòng 
Không hài 
lòng 
9. Má: 
Rất hài 
lòng 
Không hài 
lòng 
10. Tóc: 
Rất hài 
lòng 
Không hài 
lòng 
11. Tai: 
Rất hài 
lòng 
Không hài 
lòng 
 
12. Mắt: 
Rất hài 
lòng 
Không hài 
lòng 
13. Mức độ hài lòng của bạn về cách phát âm của mình?
Rất hài 
lòng 
Không hài 
lòng 
14. Mức độ hài lòng về khả năng nghe của bạn?
Rất hài 
lòng 
Không hài 
lòng 
15. Nhìn chung, bạn thấy mức độ chú ý của mọi người với khe hở của bạn 
như thế nào?
Không 
chú ý Rất chú ý 
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Appendix D: The Estonian version of the CHASQ 
Nimi Sünniaeg Täitmise kuupäev 
   
 
Mõned noored ütlevad, et nad on rahul oma kuulmise, välimuse ja kõnega, 
teised aga ei ole nii rahul. 
Kuidas sina tunned? 
Ei ole õigeid ega valesid vastuseid. 
Palun märgi iga küsimuse juures rist vastavasse kasti. 
 
Palun hinda oma rahulolu: 
1. Näo välimusega: 
Väga 
rahul 
Ei ole üldse 
rahul 
2. Välimusega üldiselt: 
Väga 
rahul 
Ei ole üldse 
rahul 
3. Profiiliga (külgvaatega):
Väga 
rahul 
Ei ole üldse 
rahul 
4. Kui hea Sa enda arvates välja näed?
Väga 
kena 
Ei ole üldse 
kena 
 
 
Palun hinda oma rahulolu:
5. Ninaga: 
Väga 
rahul 
Ei ole üldse 
rahul 
6. Huultega:
Väga 
rahul 
Ei ole üldse 
rahul 
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7. Lõuaga: 
Väga 
rahul 
Ei ole üldse 
rahul 
8. Hammastega: 
Väga 
rahul 
Ei ole üldse 
rahul 
9. Põskedega: 
Väga 
rahul 
Ei ole üldse 
rahul 
10. Juustega:
Väga 
rahul 
Ei ole üldse 
rahul 
11. Kõrvadega: 
Väga 
rahul 
Ei ole üldse 
rahul 
 
12. Silmadega: 
Väga 
rahul 
Ei ole üldse 
rahul 
13. Kui rahul oled Sa oma kõnega?
Väga 
rahul 
Ei ole üldse 
rahul 
14. Kui rahul oled Sa oma kuulmisega?
Väga 
rahul 
Ei ole üldse 
rahul 
15. Mis Sa arvad, kui märgatav on Sinu lõhe teistele inimestele?
Ei 
märgata 
üldse 
Väga 
märgatav  
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SUMMARY IN ESTONIAN 
Esimene huule- ja suulõhedega patsientide  
ravitulemuste uuring Kesk-Vietnamis 
Sissejuhatus 
Huule- ja/või suulaelõhe on üks sagedasemaid kaasasündinud väärarenguid. 
Huule- ja suulaelõhede klassifikatsiooni alusel jaotatakse lõhed kolmeks suureks 
haigusfenotüübiks: huulelõhe (CL); huule- ja suulalelõhe (CLP) ja isoleeritud 
suulaelõhe (CP). Huule- ja/või suulaelõhe esinemissagedus on keskmiselt 1/700 
elussünni kohta. Vietnamis esineb huule- ja/või suulaelõhe 1/677 elusünni kohta. 
Suulõhega sündinud lapsed vajavad ravi erinevate spetsialistide poolt ja seda 
erinevatel vanuseperioodidel sünnist kuni täiskasvanuks saamiseni, tihtipeale ka 
kauem. Seetõttu tuleb ravi kaugtulemusi hinnata erinevast perspektiivist. Viet-
namis on enamikul patsientidest tervisekindlustus, kuid paljud patsiendid looda-
vad ikkagi rahvusvaheliste abiorganisatsioonide missioonidele, mitte ei kasuta 
riigimeditsiini võimalusi. Eeltoodu on ka põhjuseks, miks suulõhede ravi Viet-
namis ei ole kooskõlas rahvusvaheliselt kasutuses olevate protokollidega. Kesk-
Vietnamisse teevad missioone erinevad rahvusvahelised abiorganisatsioonid 
(Chonbuk Ülikooli operatsioonimeeskond, Operation Smile, Smile Train, Inter-
plast, Global Care Korea) ja selliseid missioone on tehtud juba pikka aega. Sel-
lisel kujul suulõhede ravi on suunatud pigem kirurgilistele sekkumistele ning 
pikemat aega nõudvad sekkumised nagu kõneravi ja hambumusanomaaliate ravi 
ei ole tagatud. Patsientide järelkontroll on sellise korralduse juures kaootiline 
ning ravi (kaug) tulemusi reeglina hinnatud ei ole. 
Uurimustöö eesmärgid 
1. Selgitada välja hammaste tervise olukord (kaariese esinemine ja parodondi 
seisund) huule- ja suulaelõhega patsientidel 
2. Uurida huule- ja suulaelõhega sündinud lapse ema tundeid ja suhtumist 
lõhega lapse sündi; uskumusi ja kultuurilisi eripärasid ning elukorralduse 
muutust lõhega lapse sünni järgselt. 
3. Hinnata huule- ja suulaelõhega patsientide nasolabiaalset esteetikat. 
4. Luua normpatsientide nasaleerituse normid vietnami keele jaoks ning uurida 
vietnami keelt kõnelevate huule- ja suulaelõhega patsientide kõnekvaliteeti. 
5. Selgitada välja huule- ja suulaelõhega patsientide kraniofatsiaalne morfo-
loogia, hambakaarte mõõtmed, kõvasuulae- ning ülemiste hingamisteede 
struktuuride parameetrid. 
6. Uurida huule- ja suulaelõhega patsintide ning nende vanemate/hooldajate 
rahulolu ravitulemustega. 
 
Uuringu metoodika 
Uurimusse kaasati 81 huule- ja suulaelõhega patsienti. Erinevates uuringutes ka-
sutati erinevaid kontrollgruppe. Nasolabiaalse esteetika hindamisel kasutati 
kontrollgrupina 33 Eestis ravitud huule- ja suulaelõhega patsiendi andmeid. 
Nasaalsuse normide väljatöötamisel vietnami keele jaoks uuriti 102 last, kellel 
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ei olnud suulõhe diagnoosi. Lõualuude morfoloogia ja ülemiste hingamisteede 
struktuuride uuringus kasutati kontrollgrupis 24 ilma suulõhe diagnoosita viet-
namlase andmeid. Ravitulemuste hindamisel kasutati kontrollgrupina 27 Eesti 
huule- ja suulaelõhega patsienti 
Hammaste karioosse seisundi määramiseks kasutati dmft/DMFT indeksit. 
Parodontaalse ravivajaduse hindamiseks kasutati kahte näitajat: veritsust son-
deerimisel ja igemetasku seisundit. 
Suulõhega sündinud lapse ema tunnete, uskumuste, teadmiste ja pere elu-
korralduse muutuste hindamiseks kasutati avatud küsimustega küsimustikku. 
Nasolabiaalset esteetikat hindas 5 spetsialisti: näo- ja lõualuude kirurg, hamba-
arst, orthodontia resident, 2 ortodonti. Hindamiseks kasutati kolme eri metoodit: 
viie punkti esteetilist indeksit, visuaal analoog skaalat (VAS) ja referentsväär-
tuste meetodit. 
Nasaleerituse normide välja töötamiseks koostati vietnami keele spetsiifikat 
arvestav testmaterjal, mis koosnes kolmest stiimulite grupist: (1) oraalsed, (2) 
oro-nasaalsed ja (3) nasaalsed stiimulid. Nasaleerituse aste määrati nasomeet-
riga (Nasometer II (model 6450) (PENTAX Medical, Montvale, NJ), kasutades 
spetsiaalset tarkvara NasometerTM (PENTAX Medical, Montvale, NJ). Patsien-
dile esitati järelekordamiseks kõnelisi stiimuleid, patsien kordas talle esitatud 
kõnelist stiimulmaterjali kaks korda. Keskmist nasaleerituse väärtust ja 
standardhälvet kasutati andmete analüüsil. 
Näo- ja lõualuude piirkonna luuliste struktuuride ning ülemiste hingamis-
teede morfoloogia hindamiseks kasutati kolju külgülesvõtteid. Kolju külgüles-
võtted tehti aparaadiga Galileos (Dentsply Sirona, Germany) järgmiste seade-
tega: 9.4 sekundit, 60–84 kV ja 10–15 mA sõltuvalt soost, vanusest ja keha-
kujust. Kolju külgülesvõtetelt teostati tsefalomeetriline analüüs kasutades 
Dolphin Imaging tarkvara (Dolphin Imaging & Management Solutions, USA). 
Hambakaared skaneeriti intraoraalse skänneriga TRIOS® 3 Color Pod (3Shape, 
Denmark), mille tulemusena valmisid digitaalsed mudelid. Mudelanalüüsi käi-
gus mõõdeti ülakaare dimensioonid ja suulae morfoloogia. Patsientide ja vane-
mate ravitulemustega rahulolu uurimiseks kasutasime Cleft Hearing, Appea-
rance and Speech Questionnaire (CHASQ) küsimustikku. Küsimustik tõlgiti 
reeglite kohaselt eesti ja vietnami keelde. 
 
Tulemused 
Kesk-Vietnamis esines kaariest 87,2% huule- ja suulaelõhega patsientidest. 
dmft/DMFT indeksi järgi on see väga kõrge hambakaariese esinemise näitaja. 
Suulõhe diagnoosiga lastel vanuses ≤ 5 aastat oli indeks suuruseks 7.4 ± 6.6. 
Vahelduvas hammaskonnas, vanuses 6–12 aastat oli dmft/DMFT indeks 9.0 ± 
5.1 ja 1.6 ± 1.8. Huule- ja suulaelõhega patsientidel vanuses ≥ 13 aastat oli 
DMFT 6.7 ± 5.0. Olulisi seoseid ei leitud hambakaariese esinemise osas suulõhe 
klassifikatsioonist, vanusegrupist ja soost lähtuvalt (p > 0.05) väljaarvatud seos 
DMFT indeksi erinevuses vanusegruppides 6–12  ja. ≥ 13 eluaastat (p < 0.05). 
Huule- ja suulaelõhega patsientidest 60%-l täheldati veritsust igemevao 
sondeerimisel ja 5.3% (vanus > 15 aastat, n = 19) uuritavatest diagnoositi 
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igemetasku sügavusega 3.5–5 mm. Igemevao sondeerimisel ilma verituseta 
hammaste arv oli keskmisel 18.5 ± 5.2 ja veritsusega 2.7 ± 3.7. 
Suulõhega lapse sünni järgselt oli ema emotsionaalseks reaktsiooniks 
kurbus. Peaaegu pooled emadest ei osanud märkida põhjust, mis oleks võinud 
mängida rolli huule- ja suulaelõhe tekkes (47.4%). Ülejäänud emad pakusid 
suulõhe tekkepõhjuseid järgmiselt: terviserike (27.6%), ravimid (11,8%), kemi-
kaalid (3,9%), pärilikkus (9,2%). Suuremal osal emadest oli olemas tugivõrgus-
tik perekonna või abikaasa näol (92.1%). Umbes 40% suulõhega laste emadest 
ei tundnud, et nad oleksid pidanud tegama muudatusi oma igapäevaelus. Teine 
osa emadest, aga tõi esile järgmisi kitsaskohti: rahalised raskused, depression 
või raskused igapäevaeluga hakkama saamisel. Suurem osa emadest ei varjanud 
oma last teiste eest (78.9%). 
Vietnamlastest koosnevas uuringugrupis, kasutades viie punkti esteetika-
indeksit, hinnati nina sümmeetriat kõige madalamalt (2.7 ± 0.9), samas ees-
talstest koosnevas uuringugrupis hinnati kõige madalamalt nasolabiaalset 
profiili (2.7 ± 1.0). Kahe uuringugrupi vahel ei leitud nasolabiaalse esteetika 
osas suuri erinevusi (p > 0.05) välja arvatud nina sümmeetrilisus. Kasutades eri-
nevaid hindamismeetodeid nasolabiaalse esteetika määramiseks oli mõlemas 
opereeritud huule- ja suulaelõhega patsientide uuringugrupis hindamistulemu-
sed sarnased. 
Nasaleerituse aste vietnami keelt kõnelevatel normlastel oli: 13,1% oraal-
sete, 30,7% oro-nasaalsete ja 56,9% nasaalsete stiimulite puhul. Sugude vahe-
lised erinevused puudusid (p < 0.05). 
Nasaleerituse aste vietnami keelses huule- ja suulaelõhede grupis oli: 30,2% 
oraalsete, 42,8% oro-nasaalsete ja 58,7% nasaalsete stiimulite puhul. Üle 
pooltel siia gruppi kuuluvatest patsientidest esines hüpernasaalsus (52,6%). 
Täiskasvanud suulõhega patsientidel oli tunduvalt kõrgem nasaleerituse aste 
kõigi kolme stimuli puhul (p < 0.05). 
Huule- ja suulaelõhega laste näo- ja lõualuude ehituses olid järgmised 
tähelepanektud: teravam koljupõhimiku nurk, lühem koljupõhimik, lühem ja 
tagumise asetusega ülalõug, skeletaalne klass III suhe, lühem näo eesmise osa 
pikkus ja lühem alalõualuu pikkus. Samal uuringugrupil hinnati ka ülemiste 
hingamisteede struktuure ning leiti: eesmise asetusega keeleluu, väiksem suu-
neelu ruum, väiksem keelepära tagune piirkond ja lühem pehme suulagi. Näo- 
ja lõualuude morfoloogia uuring täiskasvanute grupis näitas kolmanda klassi 
skeletaalset suhet, divergeeruvat skeletaalset mustrit, lühemat eesmist kolju-
põhimikku ja lühemat ülalõualuu pikkust. Ülemiste hingamisteede mõõtmised 
täiskavanud suulõhega patsientide grupis näitasid rohkem taga pool asetsevat 
keeleluud ja lühemat pehmet suulage. 
Huule- ja suulaelõhega laste uuringugruppis olid ülalõualuu parameetrid 
vähenenud kõigis kolmes tasapinnas. Ülakaar ja ka suulagi olid kitsad, hamba-
kaar ja suulagi olid lühenenud. Esimese jäävmolaari kohalt aga puudus erinevus 
hambakaare ja suulae laiuse osas kontrollgrupiga. Täiskasvanute uuringugrupis 
olid märgatavad erinevused hambakaare ja suulae laiuste osas ning hambakaare 
ja suulae pikkuses. Suulae sügavus ja nurgad ei erinenud kontrollgrupist. 
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Patsientide rahulolu CHASQ küsimustiku erinevate näitajate osas oli üle 
normväärtuste. Rahulolu huulte ja hammastega oli normist madalama hinnan-
guga vietnamlastest koosnevas uuringugrupis, kusjuures eestlastest koosnevas 
uuringugrupis ei olnud ükski näitaja normväärtustest väiksem. Võrreldes mõle-
mat gruppi, siis vietnamlased hindasid kõikide näitajate osas rahulolu mada-
lamalt kui eestlastest uuritavad (p < 0.05) väljaarvatud kõnega rahulolu. 
Vanemate rahulolu oli kõikide CHASQ küsimustiku näitajate osas norm-
väärtustest kõrgem. Vietnamlastest vanemate rahulolu oli kõrgem kui nende 
lastel (p < 0.05), eestlastest lapsevanemate rahulolu erinevate näitajate osas oli 
aga nende lastest madalam (p < 0.05). Mõlemas uuringugrupis ei olnud tugevalt 
positiivset korrelatsioonseost vanemate ja laste hinnangute vahel. Vietnam-
lastest koosnenud uuringugrupis leiti positiivne korrelatsioonseos järgmiste 
näitajate osas: nägu, nina, huuled, hambad ja kõne. Eestlastest koosnenud 
uuringugrupis oli positiivne korrelatsioonseos ainult ühe näitaja osas, milleks 
oli nina. 
 
Järeldused 
1. Kesk-Vietnami huule- ja suulaelõhega patsientidel oli halb suutervis, väga 
suur hambakaariese esinemissagedus, esines gingiviiti age ei esinenud paro-
dontiiti. Seos leiti hambakaariese esinemise ja vanemate sotsiaalökonoomi-
line staatuse vahel. 
2. Suulõhega lapse sünni järgselt oli ema emotsionaalseks reaktsiooniks 
kurbus. Lõhe tekkes ei omistatud tähtsust üleloomulikele jõududele ega 
uskumustele. Suulõhega lapse sünd ei toonud kaasa suuri elumuutusi. 
3. Sõltumata hindamismeetodist olid nasolabiaalse esteetika hindamistulemu-
sed sarnased. Nina sümmeetriat hinnati kõige kriitilisemalt. 
4. Uuringu käigus töötati välja nasaleerituse normid vietnami keele Kesk-
Vietnami murdele. Lähtuvalt nasaleerituse normidest ei olnud huule- ja suu-
laelõhega patsientide kõnekvaliteet hea. Rohkem kui pooltel uuritavatest 
esines hüpernasaalsus. 
5. Osadel huule- ja suulaelõhega uuritavatest esines Angle III klassi 
hambumusanomaalia. Suulõhega laste uuringugrupis olid ülemiste hingamis-
teede suurus ning ülakaare ja suulae mõõtmed vähenenud kõigis kolmes 
tasapinnas. Täiskasvanud suulõhega patsientide suulae mõõtmed olid sarna-
sed kontrollgrupi uuritavatega. 
6. Nii suulõhega uuritavad kui ka nende vanemad olid rahul ravitulemustega. 
Suulõhega uuritavate rahulolu oli väiksem näitajatega mis on iseloomulikud 
just lõhe olemasolule. Hinnangute sarnasus suulõhega uuritavate ja nende 
vanemate vahel oli madalast keskmiseni. 
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